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Abstract
Infections requiring surgical revision occur in ~3% of total knee arthroplasty (TKA)
procedures. The standard treatment for TKA infection in North America is referred to as the
two-stage revision process. Unfortunately, the success rate of the two-stage revision is low, at
roughly 85%. There are indications that the two-stage revision may fail to clear the infection
due to unsatisfactory diagnostic tools. This thesis depicts the development and evaluation of
a novel telemetric sensing package designed for integration into the two-stage revision
process. Studies within evaluate its performance through sensor validation, thermal insulation
testing, radio frequency penetration evaluation, a cadaveric loading study to confirm
durability, a micro CT evaluation of the sensor’s impact on implant integrity and a
comparison of internal vs external joint temperature during joint movement.
The results of this work describe a largely effective implantable tool for measuring, logging
and transmitting diagnostic information about orthopaedic infection. Accuracy and precision
of the sensing package were found to be ± 0.24°C and 0.09°C respectively with negligible
hysteresis. Thermal insulation caused by the implant itself was found to produce a thermal
time constant of 262.67 ± 4.56 seconds, which results in a very manageable ~17 minute rise
time. Bluetooth stability was suitable for data and instruction transmission to both iOS and
Android devices while the implant was in situ. Following cyclic loading of the cadaveric
specimen with the instrumented implants installed, imaging and debridement revealed no
obvious issues related to mechanical integrity of the bone cement spacer. However, some
bone cement integration issues were observed. Although some engineering iteration and
further testing is required, this research contributes a feasible proof-of-concept platform
technology for ongoing investigation in orthopaedic infection and implantable telemetrics.

Keywords
wireless telemetry; orthopaedic infection; sensors; embedded systems; smart implant; total
knee arthroplasty; two-stage revision; 3D printing; cadaver; temperature sensing

ii

Summary for Lay Audience
Knee replacement surgeries are among the most commonly performed operation in North
America. Generally, these procedures are quite successful but occasionally complications
arise. Serious complications may require further surgery to rectify. Currently, the most
common cause for additional “revision” surgeries is infection. Unfortunately, current
solutions are unable to eliminate the infection in an alarming ~15% of cases, which may
result in serious long-term mobility challenges, amputation or even death. The hypothesis
suggests that the diagnostic tools being used are insufficient for determining infection status
during treatment. This project outlines the development of a novel sensing package intended
for seamless integration with the current North American standard treatment protocol, the
“two-stage revision”. This implantable device will collect biometric (temperature) readings
and store them for bulk wireless offloading to a physician’s mobile device for analysis.
Future human trials will be used to hopefully find a correlation between infection and mean
knee temperature during treatment.
This thesis outlines the entire design process including an evaluation of current tools,
problem definition, concept generation/selection, implementation and design validation.
During testing of this device, temperature sensing performance was evaluated using a
custom-built, programmable temperature chamber in addition to a water bath. The device
was then surgically installed in a cadaver knee to demonstrate appropriate sensing, telemetric
and mechanical capabilities while in a simulated working environment.
The exciting test performance results of this device imply great optimism, not only for the
success of the proposed project, but for sensing applications throughout the healthcare
industry.
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Chapter 1—Project Overview
Introduction

Total Knee Arthroplasty (TKA), colloquially known as “knee replacement” is one of the
most prolific surgical procedures in North America. An aging population suggests that
the popularity of this procedure is likely to continue growing.
There are several scenarios that call for a total knee arthroplasty including end-stage
rheumatoid arthritis, osteoarthritis, hemophilia, gout, disorders resulting in unusual bony
ingrowth or osteonecrosis. There also exists a plurality of other less common issues that
ultimately result sub-optimal operation of the load bearing tissues and necessitate a
replacement [1]. However, osteoarthritis (OA) is responsible for over 90% of knee
replacements so this will be a focal point of discussion [2].
Although there are various types and approaches to knee replacement, ultimately the goal
of any procedural style is to replace the bearing surface(s) and/or supporting tissue of the
knee joint with a synthetic substitute after the natural mechanisms have failed.
TKA is a generally successful surgery with low revision rates. However, the single most
common situation requiring further intervention is infection (up to 3% of cases) [3] [4]
[5].
The sheer volume of patients means that even a small percentage represents a substantial
affected population Sections 1.2.4 and 1.2.5 offer a comprehensive discussion of the
statistics, infection, diagnostics, and the gold standard treatments for TKA infection.
Unfortunately, knees requiring revision processes for infection become reinfected at a
rate of roughly 15% with devastating ramifications [6]. Although there may be several
explanations for this, Section 1.2.5 discusses high likelihood that improved diagnostic
measures for these TKA infections, specifically during the treatment protocol, would be
extremely valuable in reducing reinfection.
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Ultimately, the focus of this thesis is the engineering of a novel instrumentation and
telemetric package with the intent to log and transmit diagnostic information regarding
infection status to a physician during the treatment process. Design validation is also
presented though a combination of benchtop analyses and a cadaveric study. The
performance observed suggests promising utility not only in its current form, but the
possibility of this platform technology receiving slight modifications for more diverse
biometric applications. The majority of Chapter 1 explains the biological background and
reasoning for the pursuit of this diagnostic tool.

Motivation
Knee Anatomy
Before describing the pathway a patient takes to a total knee replacement an
understanding of the structures and mechanisms within the knee joint alongside the
ramifications of any component failing was essential. The knee is a synovial hinge joint
that translates primarily on the sagittal plane but to a lesser extent also has degrees of
freedom in the coronal and transverse planes as well.

Figure 1.1—Diagram of the right tibial tray displaying relevant internal structures.
Accessed through a Creative Commons 4.0 License at [7].
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Figure 1.2—Depiction of the right knee from the anterior direction
identifying internal structures. Accessed through a Creative Commons 4.0
License at [7].
A recent paper in the Journal of Functional Morphology and Physiology offers the basis
for the following summary of knee anatomy [8]. There are four basic elements to knee
composition: bony structures, cartilage, connective tissues, and muscles. Figures 1.2 and
1.2 (above) have been included as a precursor to the following content to orient the reader
to the relative locations of each structure.
While the knee is fundamentally a junction of the femur and tibia, the patella is an
additional, smaller bone that protects the anterior articular surfaces of the joint. It is
attached to the joint by the quadriceps tendon and patellar ligament in the superior and
inferior aspect respectively [9].
Two prominent cartilaginous structures in the knee are the lateral and medial meniscus.
They contribute to force damping and lubrication of the joint actuation. Another function
they serve is to distribute the loading evenly from one bone surface to the next despite
any geometrical inconsistencies. More load is generally applied to the medial side of the
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meniscus and as a result the cartilage of the medial meniscus tends to be stiffer than the
lateral to maintain healthy joint alignment during ordinary dynamic loading. Articular
cartilage, the primary site of osteoarthritic development envelops the load bearing
surfaces of the tibia and femur. As patients advance in age, the entire meniscus tends to
become stiffer/more fibrous and articular cartilage shows similar degenerative qualities,
especially in obese patients [10] [11].
Bone and cartilage structures of the knee are enveloped in a two layer capsule. On the
interior of this capsule, the synovium membrane secretes a lubricating fluid to assist and
nourish the meniscus. The exterior layer of this capsule is comprised of five connective
tissues. The quadriceps tendon joins the quadriceps to the patella. The medial and lateral
collateral ligaments (MCL/LCL) stabilize the inner and outer portions of the knee
respectively while the anterior and posterior cruciate ligaments (ACL/PCL) reduce
forward and backward translation of the femur relative to the tibia.
Finally, there are two major muscle groups that cause the primary knee translation.
Hamstrings run along the posterior of the femur and attaches just below the knee on the
tibia. Quadriceps are four muscles that run along the anterior side of the femur to oppose
the forces imparted by the hamstrings.

Osteoarthritis
The previous section outlined the overall knee anatomy and should orient the reader to
how some of the concepts covered in this section might result in insufficient function.
Osteoarthritis is a disease resulting in the deterioration of articular cartilage, reducing the
performance of load bearing joints and causing pain. One key characteristic of this
disease for the time being is that physicians can often treat symptoms and slow disease
progression, but there is no outright cure [12].
The pathology of OA is well characterized and generally known to progress in a few
steps. It begins with the chondrocytes becoming unable to support loading applied in
some regions of the cartilage. This is generally because of non-uniform loading, chronic
or acute overloading. Their natural reaction is to cluster and excrete more growth factors
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into the extracellular matrix (ECM), effectively an inflammation response. This is normal
cartilage behavior For much of the joint lifespan the articular cartilage can heal from this
response by stimulating the regeneration of chondrocytes. However, when this fails to
result in the desired healing, the chondrocytes undergo apoptosis at a higher rate than
new ones are created and the ECM breaks down, leaving unsupported collagen fibers. At
this stage the articular cartilage has somewhat “deflated”, and it becomes tough/fibrous.
The end stage of OA involves bony ingrowth into the already toughened cartilage. This
stage generally escalates to a bone-on-bone grinding effect.
Generally, treatment strategies taken are targeted around the early-stage inflammatory
response. If the severity and length of that phase can be reduced, there is a higher
likelihood that the cartilage will be able to replenish chondrocytes naturally [13].
Especially when it is caused by an acute injury. At this stage, the goal is to make
chondrocyte production happen more quickly than apoptosis in order to prevent the ECM
from becoming depleted.
Once the cartilage deteriorates beyond this point, the unsupported collagen becomes
damaged from loading and there are few treatment options so knee replacement is
considered [14]. The function of a knee replacement in this context is to completely
remove the problematic cartilage and bone surfaces, leaving behind a low friction
polyethylene on polished metal bearing surface in its place.
More recent research indicates that beyond the classical understanding of OA, there may
be additional factors involved, specifically a discussion of bony ingrowth beginning in
some regions of the cartilage prior to ECM collapse, thus creating the non-uniformly
distributed loading/stress raisers commonly accepted to initiate OA [15].
This section previously alluded to total knee arthroplasty as the ultimate termination of
treatment for osteoarthritis. For clarity, the Section 1.2.3 is a dedicated explanation of
that process and depicts how TKA simply replaces the components failing to perform
properly as OA progresses.
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Total Knee Arthroplasty
Total knee arthroplasty is one of the most prolific surgeries in North America with
~700,000 performed annually [16]. TKA surgeries have become a fairly streamlined
process with ever decreasing average length of stay in hospital and longer implant
lifetime attributed to innovative design and improvements to healthcare [17]. Revision
TKA surgeries in Canada for 2016–2017 were just 7.6% of total TKA surgeries, noting
some of them would have been patients having components of their knee revised
following a decade or more of good function [18].
Although strategies differ somewhat, specifically in the preservation of various
supporting tendons and ligaments, this is a summarized procedure for TKA adapted from
Varacello et al. [19]:
1) An incision is made across the anterior knee running in a proximal to distal
direction. Note that minimally invasive approaches are now gaining popularity
with shorter incisions.
2) The patella is moved to the side, permitting access to the articulating surfaces of
the knee.
3) An intermedullary drilling operation is performed to permit access to the femoral
canal.
4) Fixturing, guides, or other alignment equipment is affixed in preparation of an
involved resection process on the femoral condyles. This fixturing is often located
about the femoral canal geometry and pre-operative alignment analysis.
5) Surgical guides or fixtures are frequently used in resecting the tibial articulating
surface to produce a flat surface on a plane that best supports proper knee
alignment. Often a plane normal to the tibial axis is chosen, but other times a
slight (2–3°) varus bias is applied.
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6) The knee extension gap magnitude and geometry is assessed. This is often done
by utilizing a spacing block in extension and an anteroposterior sizing guide in
flexion. Adjustments to cutting guides affixed to the femur are applied as
necessary.
7) The femur is resected with an anterior, posterior, anterior chamfer and posterior
chamfer with assistance from installed surgical guides.
8) An intercondylar notch is cut from the femur, perpendicular to the native
transepicondylar axis.
9) The femoral and tibial implants are either impacted or cemented in place. Care is
taken to avoid internal rotation or component overhang. A polyethylene bearing is
mated to the tibial component, sized to produce the desired joint geometry.
Alignment is confirmed and the bearing may be switched if needed.
10) In some cases, the patella will also receive a bearing on the posterior surface.
11) The patella is repositioned, and the wound is closed.
While this description should clarify the process, the takeaway message is obvious: as
OA progresses it causes the articulating cartilage and supporting bony structures to fail,
this procedure simply replaces the regions that OA affects. It does however come with
some risk, the most common of which is covered in Section 1.2.4.

Infections of Total Knee Arthroplasty
A drawback of any surgical procedure is risk of infection. It has been suggested that up to
5% of patients receiving any kind of surgery will develop a “surgical site infection” [20].
Revision rates in total knee arthroplasty attributed to infection are considerably lower
than this at 1–3% of patients depending on the source [3] [4] [5] [21] [22] [23]. When
considering the quantity of TKAs being performed annually in Canada (70,000) and the
United States (>600,000) as many as 20,000 North American people require infection
related revisions annually [18] [24].
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Upon investigation of the types of infection, there are reports that 52.9% of infection can
be attributed to staphylococcus, 5.9% to Escherichia coli, and 2.8% anaerobes. Other
sources report that staphylococcus is the sole pathogen in 67.7% of cases while
streptococci (another member of the Gram-positive bacterial group) was implicated in
19.2% of cases. Song et al. published results highlighting candida albicans in TKA
infection, which implies fungus is another causative microorganism [25].
An infection, especially untreated, can be devastating. There are some intuitive symptoms
including local heating, swelling, and pain. These localized symptoms can quickly
progress to systemic infection, resulting in high fever, sepsis or even death [21] [26] [27]
[28] [29]. This is coupled with up to 24× cost increase in overall treatment pathway for a
patient who develops a periprosthetic joint infection (PJI) [30]. An additional challenge is
that sometimes the symptom severity is low for a substantial period of time, meaning the
patient is less likely to seek medical attention while in the meantime, an infectious
biofilm is being formed on the implant components causing extreme infection resiliency
[27].

Diagnostics & Treatment of Total Knee Arthroplasty Infection
Having understood the manifestation of infection in TKAs as discussed in Section 1.2.4,
it became important to consider the methods currently being used to diagnose a primary
TKA infection.
There are common clinical indicators of high interest as usually they are the easiest to
observe by patients and primary caregivers at a glance. These indicators include
persistent pain, swelling, erythema, localized warmth or wound drainage. Note that there
are also examination findings that surround general tenderness and range of motion
disproportionate to healing timeline, but if the infection is an “Acute PJI” (occurring in
the first 4 weeks following surgery), it is difficult to discern ordinary localized pain or
limited range of motion from an indication of infection so these two indicators are more
valuable when evaluating a “Chronic PJI” (≥ 4 weeks post-surgery). Sensitivity of these
evaluations are not as high as some other measurements, largely because meaningful
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quantification of these symptoms is challenging. Also, they can be caused by other
reasons (related or unrelated to the surgery) [30].
Serological tests are also popular tools, the two mainstays are erythrocyte sedimentation
rate (ESR) evaluation and C-reactive protein (CRP) tests, although new markers such as
IL-6 are being investigated [3].
ESR is a nonspecific indicator of inflammation that generally peaks 5–7 days following
surgery and then decreases to a baseline over 3 months to a year. Ongoing ESR elevation
is indicative of infection. It involves agitation of blood or serum and then measuring how
long it takes for the red blood cells to separate/settle. ESR is imperfect however, featuring
just 82% sensitivity and 87% specificity [31].
CRP is another inflammation correlated indicator, but it works differently than ESR.
While ESR is not concerned with relative concentration, more so mechanical behavior,
CRP testing is specifically checking the serum for concentration of these proteins. If CRP
stays above a threshold of 10 pg/mL 14–21 days after TKA, the patient is still considered
“infected”. Performed together, these tests have a sensitivity of 91% and specificity of
86% [31].
In some cases, the use of imaging tools to evaluate infection of TKA are used.
Conventional radiography may be applied following the clinical observations above to
seek any kinematic reasoning (such as fracture, loosening, or positional change) for the
observed inflammatory symptoms instead of infection. This modality cannot specifically
indicate that a patient is or is not infected, it can only positively identify kinematic
abnormalities, which might be an alternative cause of symptoms [3].
There are various nuclear medicine approaches to imaging TKA infection, specifically,
triple phase technetium-99 bone scan (TPBS), white blood cell (WBC) imaging using
indium-111 as the emission source, or fluorodeoxyglucose positron emission tomography
(PET). These modalities are applied to evaluate the bone remodelling behaviors or
inflammatory responses and the correlation to infection. One source reported the overall
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accuracy of these modalities as 81%, 84%, and 83% respectively in detecting TKA
infection although no precision figure was offered [32].
Joint fluid/tissue analysis is another subcategory of PJI analysis. Knee aspiration involves
using a syringe or vacuum device to extract fluid from the joint space. This can be
performed simply to reduce pressure, but the synovial fluid collected can also inform
physicians about the infection conditions after subsequent analysis [33].
The extracted aspirate can be sent for several different lab evaluations, which when
combined, are one of the most effective ways to identify a primary infection. If there are
>1100 leukocytes/ml of synovial fluid, and the amount of neutrophil (a type of
leukocyte) as a percentage of the overall quantity of leukocytes is in excess of 64%, one
can be 98.2% certain of infection. This confidence decreases when either one of these
counts is below their respective thresholds [34]. Although very useful, there is one major
drawback: if the patient has taken any antibiotics in the previous 4 weeks, these
measurements plunge in reliability such that they are more suitable for an initial
diagnosis than monitoring recovery as most patients will be put on antibiotics once the
infection has been discovered [35] [36].
Although fungal infections are rare by comparison to bacterial, they do require their own
evaluation strategies. While the clinical indicators of infection do still apply, usual joint
aspiration protocols will not detect fungal infection. As a result, some hospitals choose to
conduct a “potassium hydroxide mount” (a histological analysis) to rule out this
possibility [37].
Once a patient has been diagnosed with an infection, there are some common options for
their treatment. The preferred option is the cheapest and least invasive. It involves
antibiotic suppression of the infection and is often coupled with irrigation and wound
debridement but ultimately aims for implant retention. This is an easier solution for all
involved, but there are two caveats:
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1) These are only options for an acute infection diagnosis. Any infections older than
4 weeks are assumed to have a developed into a deep infection or biofilm and are
notoriously resilient [27].
2) Recall, once antibiotics are administered, the utility of the conventional aspiratory
testing is severely compromised, so measuring treatment progress is difficult [34].
If the above fails to clear the infection, or the infection has been otherwise classified as
“chronic” then it becomes likely that the region of the world the patient is in will dictate
their treatment pathway.
In Europe, most patients should expect to undergo a single-stage revision (SSR) process.
SSR involves one surgical procedure during which the infected implant is removed, any
infected or necrotic tissue is resected, intermedullary canal is reamed, and insertion of a
new “revision” implant meant to be a permanent replacement is cemented in place using
a bone cement laced with antibiotic [38].
In North America, an alternative strategy, the two-stage revision (TSR) is preferred. As
one might infer, a TSR involves two separate surgeries. The first does a lot of the same
that the SSR does, but instead of aggressively reaming the canal to fit the revision knee at
this stage, a smaller diameter cut is taken and an antibiotic loaded bone cement “spacer”
is installed instead. This spacer passively elutes antibiotics and offers some surface
antibiotic properties, which works to discourage the reformation of a bacterial biofilm on
the implant surfaces. During this phase the patient is often dosed with a battery of oral
and/or intravenous antibiotics. The spacer is recommended to remain in the patient for a
period of approximately 6–10 weeks as the infection is cleared before another surgery is
conducted to debride the spacer, ream the mating surfaces, and install the permanent
revision total knee implant [38] [39].
Both solutions can be effective in their own way, but they certainly also have drawbacks.
There are some suggested advantages of SSR over TSR. For example, if the revision is
successful an entire surgical procedure is avoided. This is advantageous from a cost
perspective but also means that the patient has one fewer operation to develop a
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complication during and the patient recovery timeline can be expedited [25]. Although a
concrete figure in knees has proven difficult to find, the same debate applied to hip
arthroplasty in Australia suggests the cost difference between SSR and TSR is slightly
more than 50% in an ideal SSR [40].
There is suggestion of some infection eradication advantage to two stage revision over
SSR for several reasons. First, in TSR procedures the physician has the opportunity to
revise to another spacer if they are unconvinced that the infection has been cleared in the
treatment period of the first one. Furthermore, patients are more likely to have the bone
volume remaining to permit these revisions because the tissues have not already been
reamed out to fit the (wide bore) permanent knee as they would have with SSR [41].
Turning a two stage into a three stage revision has drawbacks but it is still preferable to
reinfection of the permanent revision implant. Second, the volume of local antibiotics is
increased over SSR with much more bone cement being used and therefore the useful
elution period is also increased. Third, an antibiotic bone cement spacer leaves only
antibiotic laden, non-metallic surfaces in the joint space. Assuming the right antibiotics
are used, this creates a poor environment for biofilm formation and greatly reduced
infection resiliency [42]. TSR strategy allows physicians to choose whether they are
going to use a cemented or cement-less total knee revision implant on a case-by-case
basis where SSR demands a cemented installation as the antibiotic cement is considered
critical to the process [6].
When examining literature to compare the effectiveness of each style, it becomes clear
that several factors negatively impact the chances of a fair comparison. It is easy to
innocently introduce sampling bias into a comparative study in favour of SSR. This is
because poor bone quality is often contraindicated for SSR so patients less healthy at preoperation are more likely to receive TSR by default. Also, there may be some pressure to
produce results in favour of SSR, especially in places where the healthcare payor is the
same entity producing research funding. A well randomized, unbiased clinical trial is
really needed to know with certainty which strategy is superior [38].
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Regardless, the entire field can agree upon two things:
1) Both methods produce unacceptably high re-infection rates. A comprehensive
2019 review paper suggested ~15% reinfection for both strategies [6].
2) The ramifications of a “permanent” joint revision implant becoming reinfected are
absolutely devastating, generally ending in lifelong mobility issues, amputation or
mortality. Not to mention huge healthcare cost associated with reinfection, one
study suggests a hip a reinfection costs roughly 5 times the price of a standard
SSR [40].
One might find the high reinfection rate following either procedure unsurprising.
Recalling discussion on diagnostic tools, the most common ones, leukocyte quantity and
relative neutrophil content analyses following joint aspiration are negatively affected by
antibiotic use. C-reactive protein tests are challenged as well, considering CRP levels
change rapidly with variable inflammation levels [43]. It is reasonable that the same
strategies used to diagnose a primary infection are not particularly suitable once the
patient has begun their antibiotic therapy and enters the dynamic process of potential
surgery and healing. There is the need for a better type of diagnostic tool for use once
treatment has begun.

Problem Definition, Thesis Scope & Hypotheses
To review, this Chapter has offered discussion of the knee joint, the primary causes for
replacement, the fundamental mechanism with which this is done, and some known
issues with the process.
Section 1.2.5 offered detailed account of the infection related statistics, protocols and
problems. This ultimately resulted in the argument that the current methods of monitoring
infection status, specifically during treatment, are insufficient and improved diagnostic
tools for this phase of recovery are required.
This suggests a problem definition. “Develop a diagnostic solution specifically suitable
for use during treatment for total knee arthroplasty infection.”
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The scope of this task was limited to address patients undergoing two stage revision
considering a North American patient’s most likely treatment pathway and the treatment
protocol Canadian physicians are most comfortable with.
Tests observed working well at steady state (infected, or not infected) become less
effective during recovery, either due to dynamic conditions or due to antibiotic
interference [34].
Even the most rudimentary systems can only be accurately characterized and usefully
leveraged with suitable data. To capture data needed in mapping a dynamic system, the
key is almost always measurement over time [44]. When viewed from this perspective,
reports of poor testing reliability during recovery seem reasonable if not probable. Every
test for infection conducted on these patients comes down to a measurement every few
weeks when the patient comes into clinic. How could any physician be expected to
extrapolate on a continuously changing system with a sample rate of 1–2 times per month
at an accuracy any higher than the current 85% when it is known some tracked metrics
fluctuate by the hour [45] [46] [47]?
Recent advancement in embedded systems, wireless communications, sensors, and
implant-safe batteries mean that innovators have the tools to offer physicians higher
frequency information to aid in their treatment strategies. A patient may be sent home
with an implantable or wearable sensing package that can collect and log biometric
measurements every few minutes for later presentation of this telemetry (trended over
time) to the physician. Medtronic has pursued this strategy for several years in the field of
cardiac arrythmia monitoring with FDA approval of their temporary LINQ™ implant and
shown improved clinical outcomes by monitoring “at risk” patients remotely [48]. At this
time, the researchers are unaware of any orthopaedic infection sensing equivalents.
By eliminating metrics inherently affected by antibiotic use and imaging modalities
(infeasible to send home), this left a few choices for measurable indicators that may be a)
correlated to infection status and b) converted into valid indicators by higher sample
rates: functional pain, swelling, temperatures, ESR, and CRP measurement.
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An evaluation of functional pain was discounted, the quantification of pain is an ongoing
question so a sensing modality capable of measuring it in this context and timeline was
unrealistic.
Erythrocyte sedimentation rate involves extraction of blood, timing of settling, and
observation. Although very recent advancements in micro electromechanical systems are
producing some incredibly interesting work on the topic of miniaturizing this test, a
commercial embodiment of this technology, especially one feasible for implantation is
years from reality [49].
C-reactive protein secretion is directly linked to inflammation, so “swelling” is also
grouped into this category. This test has some real feasibility in implantable evaluation. A
2009 paper by Hsaio Chen et al. showcased an intriguing design for a MEMS chip
capable of fitting a small lab-on-chip setup for this measurement in a 7 × 7 mm package.
Unfortunately, this technology never made it to retail, likely because of the inherent
sensitivity to micromanufacturing tolerances and complicated tuning processes making
this a difficult sell [50]. If this technology were to appear commercially, it would be a
great addition to this project.
The field of thermal measurement, both the sensors and system modelling, is well
researched with dozens of high-quality sensors are available off-the-shelf. Another large
advantage relative to other alternatives is that temperature can easily be measured
through conduction if needed, which is advantageous from a biocompatibility/isolation
perspective. Temperature sensing for infection monitoring does have challenges
involving passive wound heating due to healing, and diurnal rhythm may have an impact
as well, but these will later be discussed in detail.
At this stage, a decision had to be made: implantable or wearable? On one hand,
implantable technologies come with many technical challenges like regulatory approvals,
power supply, communication, and biocompatibility. On the other, wearables are likely to
be less sensitive to joint space infection than an internal temperature measurement [51].
Most critically, a patient can remove it which brings up the dreaded topic of optional
adherence. Under different circumstances the decision might have been more difficult,
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but in this specific context, casting the sensing package directly into the antibiotic bone
cement spacer simplified the technical challenges associated with implantation greatly,
while removing adherence from the equation making implantation very attractive.
After careful consideration, and a deep-dive into existing technology developed for
similar sensing applications (Section 2.1), it was decided to produce an orthopaedic
implant integral to the bone cement spacer. This device is meant to capture and store
periodic measurements of implant temperature, several times an hour, for weeks at a time
between clinical visits. When the patient visits the clinic, the data will be wirelessly
transmitted to the healthcare provider(s) to be evaluated for indications of infection
subsidence or worsening.
The following pages depict development, fabrication, characterisation, and validation
strategies of a device that may lay the groundwork for a fundamental change in
orthopaedic infection management.
While this thesis is certainly design-heavy, it is not proposed in the absence of research
questions. The researchers suggest two hypotheses:
1) The sensing package developed will offer sufficient sensing, power management,
and communication performance to be feasibly used for the application of
infection diagnostics in a knee spacer.
2) The integration of the overall instrumented package within a bone cement spacer
is unlikely to cause mechanical or logistical issues during installation or use.
Section 1.4 clearly lays out the contents of each Chapter.
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Thesis Outline
CHAPTER 1

Project Overview – Introduces the knee anatomy, total knee
arthroplasty, infection related conditions/diagnostics/treatments, the
problem definition and a high level design approach.

CHAPTER 2

System Design – Summarizes the sensing history of implantable
devices. Project then broken into sub tasks. Engineering design
thinking applied to each individual issue involved in the design of the
instrumented implant. Manufacturing of sensing package discussed.

CHAPTER 3

Experimental Evaluation of Prototype – Testing of the prototype
including an evaluation of sensor precision, hysteresis, sensor
accuracy, thermal time constant of cemented package, wireless
communication from within a knee, data collection during anatomic
loading, and instrumented spacer survivability.

CHAPTER 4

Summary, Discussion & Conclusion – A final discussion of device
performance, observations, future work is included and commentary
regarding the high level ramifications of this project.

The objectives of this study were as follows:
1) Characterize the sensing device to identify a characteristic equation, sensing
precision, sensing accuracy, and the thermal time constant of the cemented
implant.
2) Assess wireless transmission of the device's temperature readings while in situ,
and during exposure to anatomically relevant cyclic loading.
3) Investigate the integration of the sensing package within the bone cement spacer
using imaging and destructive analysis.
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2

Chapter 2—System Design

Having understood the need and problem definition, this chapter examined the history of
sensing in orthopaedics and cover the design process this team underwent in the creation
of a potential solution to infection diagnostics during two stage revision.

Data Collection & Logging in Medical Applications
In highly academic fields, data driven decision making is essential “due diligence” and is
what differentiates medicine from homeopathy. Quantitative measurement using
implantable devices has been a research focus for decades, below is a brief summary.
Force sensing has historically been the primary driving factor for orthopaedic
instrumentation as engineering decisions in implant design required quantitative
information to form constraints. Implant instrumentation solutions originated in 1979. T.
English and K. Kilvington published a paper depicting in vivo sensing of hip loads using
an instrumented femoral implant [52]. The implant was primitive in design, utilising
strain gauges positioned to measure axial loads with a battery powered transmitter. The
battery and transmitter were encapsulated externally to the main body of the implant, but
still inside the patient’s leg. Although the battery chemistry and transmission method
were not discussed, it can be assumed that this system was non-rechargeable and
communicated via low frequency radio waves to a dedicated receiver. As this implant
was intended to be a permanent device, it is unclear if the battery and transmitter were
intended to remain inside the body or be surgically detached from the rest of the implant
and removed when depleted.
Shortly afterwards, in 1982, R. Brown et al. published a study depicting a more
sophisticated device [53]. Their invention was a hip nail offering strain measurement
about two separate degrees of freedom. It applied conventional FM radio technology to
transmit readings, requiring impressive ingenuity as they transmitted two separate
readings on a single frequency using no digital components. They effectively multiplexed
the signal output using oscillators of asynchronous frequency (5 kHz and 4 kHz). Each
oscillator fed a signal through one of the strain gauge (modified Wein) bridges, which
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determined the amplitude and then both signals were superimposed for transmission.
Signal deconstruction could then be performed by filtering out the 5 kHz and 4 kHz
components using external computation hardware. Unfortunately, the oscillatory nature
of this measurement strategy resulted in poor strain gauge performance. This was the
most complex telemetric orthopaedic implant found prior to the use of onboard
computational hardware separating the measurement circuit from transmission.
The industry was relatively quiet for several years until the early 2000s as researchers
waited for more compact and power efficient mobile computing chips, better implantable
battery technology, wireless charging options, and improved wireless communications.
At that point, two groups took control of the orthopaedic sensing space.
Dr. D’Lima published a paper depicting a paradigm shift forward in this type of
technology [54]. His team developed a knee implant that had computation available
onboard utilizing an advanced (for the time) PIC16C microcontroller unit (MCU). This
change permitted a separation of the power management, sensing, and transmission
circuits. This device did not have an onboard power supply, rather relied on wireless
excitation through an inductive coupling and rectification circuit. The microcontroller
permitted several force sensors to be sampled sequentially and an integrated analog to
digital converter (ADC) allowed digitization and therefore short-term storage of readings.
The PIC16C also permitted integration of a radio frequency element allowing D’Lima’s
team to stream digitized readings to a proprietary receiving unit while the study subjects
performed movements in his laboratory. Because this implant did not have a power
supply, it relied on the patient being in the lab and hooked up through an inductively
coupled knee brace to a power supply for excitation and reading capture. The upside to
this mechanism was that there is nothing dangerous about leaving the instrumented
implant in the body for an indefinite period as there were no batteries to leak.
Shortly thereafter, a German company called Orthoload collaborated with the Julius
Wolff Institute to construct a device in this space considered the closest to “commercial”
in instrumented orthopaedics. They have designed several orthopaedic implants for
different joints that can collect kinematic information for 6 axis acceleration, loading, and
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coarse resolution (~1°C) temperature [55]. Functionally it operates very similar to Dr.
D’Lima’s solution, but they can include more sensing options due to a proprietary
integrated circuit design. Orthoload does not sell these devices as commercial joint
replacements for hospital purchase, instead they run clinical trials and sell the databases
of collected kinematic information to research centers interested in developing their own
(passive) implants, external prosthesis or other orthopaedic aids.
One final technology to discuss is not orthopaedic, but cardiac. Between 2014 and the
present, St. Jude/Abbott Medical and Medtronic have produced at least four different
implantable cardiac monitoring devices available for commercial use in the US. They
allow remote monitoring with the ability to observe events between clinical visits and
have been shown to capture 7.8 times more atrial fibrillation events in cryptogenic stroke
patients (who are already closely monitored) over the course of one year [56].
The Medtronic LINQ (and competitive devices) set an approvals precedent for a
clinically viable, battery powered implantable devices with the sole function of
measuring a biological stimulus, logging that information over time, and wirelessly
transmitting it to a physician for improved diagnostic capability over standard care. The
adoption of this device bodes well for the approval of a similar device in orthopaedic
infection sensing, which is the gap in technology that will be addressed in this thesis.

Embedded Systems & Wireless Telemetry
The rise of mobile computing is perhaps the most defining technological shift of the
2000s. It is difficult to pinpoint when the mainstream uptake began, some might argue the
earliest pocket calculators, perhaps the earliest cell phones, but the 1996 PalmPilot1000
seems most representative of the beginning of modern mobile computing. Widely
accepted customer requirements for mobile computing have remained largely unchanged
since this first touchscreen handheld was designed: compact, lightweight, long battery
life, quick performance, more storage, more connectivity, more multitasking capability,
and low cost [57]. Microprocessors and their peripherals are a major design consideration
for development of any mobile device as they influence all these priorities. For decades,
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major manufacturers have consistently one-upped each other resulting in rapidly evolving
mobile computing possibilities and the “smart” ecosystems.
When selecting the computational platform for this device, a degree of versatility was
required as the MCU was one of the first components selected. At this stage, it was
unclear what other components might be selected, so flexibility to integrate several
different types of sensors, power supplies, and wireless communication strategies was
advantageous.
To permit an 18–month design, fabrication and validation cycle, one constraint was a
platform supported by a well-equipped development environment. An associated
objective to find a pre-built package that would not require a custom printed circuit board
(PCB) layout. The obvious caveat being an overall package size suitably small for an
implantable application and availability of suitable hardware.
There was a necessity for a solution offering low sustained power consumption to afford
the most flexibility in power supply. A target value was not chosen, but provided the
selected platform was constrained to have some form of software-interruptible
sleep/standby state, the net current draw for the MCU would be dwarfed by the power
consumed for wireless transmission anyways.
To ensure compatibility with any potential sensor, it was preferable to have a
microcontroller that contained an 11 + bit ADC, plus offered both Serial Peripheral
Interface (SPI) and Inter-Integrated Circuit (I2C) communication options. Between these
three options the selected microcontroller would be suitable to interface with nearly any
commercially available sensor.
There was substantial motivation to select Bluetooth as the wireless modality. Most
modern smartphones, laptops, and tablets offer Bluetooth as a native transmission feature.
This sensing package was designed not only as a research tool, but also to be
commercially viable. The cost reduction and ease of implementation if physicians could
connect using their own devices so no dedicated transponder was required was extremely
attractive. Suitable data security strategies for Bluetooth are also easy to implement
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relative to some less popular technologies. However, it has been shown that 2.4 GHz
signals do struggle to penetrate water. Literature suggested that Bluetooth should be
capable of transmitting over the relatively short tissue depths required but there was
certainly the objective to select a system that would permit an easy pivot to lower
frequency communication should Bluetooth fail to penetrate the leg [58].

Concept Generation, Selection & Implementation
With these considerations in mind, the following four concept solutions were examined:
1) MbientLabs MetaMotion C

Figure 2.1—Mbientlabs MMC
microcontroller as depicted with ruler for
scale. It is a 25mm ARM based MCU with
extensive peripheral support.
The Mbientlabs device shown in Figure 2.1 is a complete system, with integral
microprocessor, Bluetooth antenna, several sensors, and plenty of sensor communication
options. It is available with an integrated development environment (IDE) permitting C
level language coding and wireless firmware updates. It was on the larger end of
considered systems, a circular package of 25 mm diameter and is manufactured by a
growing Chinese start up manufacturer [59].
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Figure 2.2—TI CC2650MODA microcontroller as
depicted with a ruler for scale. It is a thumbnail
sized device with a rich featureset.

2) Texas Instruments CC2650MODA
Texas Instruments (TI) has a rich heritage of mobile computational platforms and has
recently produced a series of “SimpleLink” processors designed to make connected
systems and “Internet of Things” a straightforward process. They make a range of chips
that share similar architectures and identical pinout, but each integrates a different flavour
of wireless capability. The suggested offering pictured in Figure 2.2 offers Bluetooth
Low Energy (BLE) connectivity and an antenna integrated together on one small 10 × 12
mm PCB. This is designed to be soldered down to a custom breakout board containing
sensors and a power supply of the engineer’s choosing with a full host of analog/digital
input/output (IO), I2C, and SPI ports. For an additional fee, TI offers a prototyping kit
and an IDE accepting a modified version of C programming [60].
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3) ELSRA BT03

Figure 2.3—ELSRA BT03 microcontroller as depicted with a
ruler for scale. It is seen here soldered down to a supplied
breakout board.
ELSRA Electronics is a company based in Shenzhen, China. The BT03, seen in Figure
2.3, is a clone module of the CC2650MODA above but applies a newer, superior, TI
processor (CC2640R2F). This module offers increased storage space and the ability to
connect via BLE or Bluetooth 5.0, but at slightly higher cost. In theory, the same Texas
Instruments prototyping kit and IDE are compatible [61].
4) Arduino / Arduino Compatible Systems
Systems like DFRobot’s BLE Beetle and competitors are capable, yet ultimately
impractical modules. Arduino is extremely intuitive with excellent community support
designed specifically to permit quick “minimum viable product” creation. Although it
seemed like an obvious choice, there appears to be a surprising gap in technology. Even
the smallest Bluetooth capable Arduino compatible devices are 25 × 33 mm and are not
designed to be soldered down to a breakout PCB. Another challenge is that most of these
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compact Arduino compatibles are sold by small third parties. This invited the opportunity
for supply chain issues [62].
In the concept selection phase, reduction was conducted using a Go/No-Go Screening,
which can be seen below in Table 2.1. This screening strategy eliminates potential
solutions that “fail” any of the design constraints.
Table 2.1—Go/No-Go screening of embedded system solutions. This is an
engineering selection tool for filtering considered devices.
MbientLabs
MMC

TI CC2650MODA

ELSRA
BT03

Arduino
Compatible

Sleep/Standby

Go

Go

Go

Go

Good IDE

No Go

Go

Go

Go

Compact

No Go

Go

Go

No Go

ADC, SPI & I2C

Go

Go

Go

Go

Bluetooth

Go

Go

Go

Go

Result:

Fail

Pass

Pass

Fail

The Texas Instruments and ELSRA platforms emerged from preliminary screening as the
only solutions satisfying all constraints. Due to their similarities and low cost, they both
would score competitively in an Engineering Decision Matrix so both solutions were
purchased and tested.
Although powered by a superior processor, the ELSRA BT03 arrived with poor
documentation and upon further inquiry, the customer support team was unable to
implement their own hardware as advertised.
The TI branded CC2650MODA module also was not provided with thorough
documentation for this application. It was originally designed to be applied as a Bluetooth
transceiver module acting peripherally to a master microcontroller in a larger
implementation. Nonetheless, the hardware capability did exist for it to be used in a
standalone configuration and the Texas Instruments engineering staff were extremely
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willing to provide additional resources. Using the TI Code Composer Studio IDE,
software for this implant was developed in house. A custom PCB breakout to attach the
sensor, a power supply, and breakaway programming interface was created.
The ultimate package size is just 12 × 17 × 3mm, about half the size of the smallest
available Arduino platform. This platform also leverages three separate controllers on a
single integrated circuit and managed by a real time operating system. The CC2650
includes a primary Cortex M3 processor in addition to a dedicated “sensor controller”
and an “RF core” all on one 5 × 5 mm chip [60]. The peripheral processors can
sleep/wake asynchronously from the main processor. This permits the power hungry M3
to idle or perform other tasks as the sensor controller independently samples the
environment, stores the readings temporarily, and offloads them as appropriate to the
Cortex M3. Similarly, the RF core has its own buffer to store and transmit information it
has received wirelessly. As a result of this technology, the CC2650MODA can operate
for months or years on a standard CR2032 coin cell depending on the application. It also
has enough storage space after this device’s programming to hold 5500 readings before
requiring a wireless information transfer to the physician’s phone. At such a time, the
storage is wirelessly cleared, and further samples can be collected over several more
weeks.
With the MCU selected, the next decision in the process was to determine which sensor
would be selected for use. This is discussed in Section 2.3.

Temperature Sensing
It was decided early in the problem definition phase of this project that temperature
sensing would be the operative biometric marker for this implant. Elevated temperature is
a known indication of infection as the body’s immune system aims to weaken an
infection with a localized or systemic feverish response [63]. Temperature sensing is
likely to show some challenges in separating an infection “signal” from thermal “noise”
resulting from factors discussed below but recalling Section 1.2.5, all metrics have
individual hurdles. Temperature sensors are at least a mature technology, with alternate
stimuli like ESR there would be concerns about performance of a novel sensor type in
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addition to the questions about overall infection correlation. Note that the controller
chosen in Section 2.2 was selected with the possibility of a future pivot to an alternate
sensing modality as an alternate sensor would be almost “plug and play”, but prior to
clinical testing, temperature sensing was the most logical starting point.
The first challenge was to determine a sensing resolution, precision, and accuracy that
would be appropriate for this application. To be clear, resolution refers to the minimum
detectable change, precision is synonymous with the standard deviation of a sensor
reading at any given steady state condition and the accuracy refers to a range surrounding
the “true” value of temperature reported by the sensor.
The decisions for appropriate constraints were challenging as is the first implantable
sensor for this purpose. No dataset exists to say “if the patient is below X temperature for
Y amount of time, the patient’s infection is cleared”. This will have to be discovered
experimentally and is unlikely to be a single threshold value for all patients.
An investigation of expected temperature ranges began with an evaluation of previous
literature. Research of “diurnal rhythm” – the body’s natural temperature fluctuation over
time, was an initial consideration. Healthy human males have an average range of 0.9°C
core temperature fluctuation throughout a 24 hour period, where females may show
additional daily increase of up to 0.4°C depending on their menstrual cycle and other
hormonal factors [64].
Other considerations included the observed increase in postoperative knee temperatures
as recorded in healthy patients. A 2016 study published by Yirong Zeng et al. suggests
that 5 days post-op, TKA patients experience an average increased knee skin temperature
of 2.3°C relative to the contralateral knee, which stays fairly steady until the 30 day
measurement. By 90 days, this temperature has begun to subside to 1.8°C. Their
measurements were taken with a medical IR thermometer (Optris GmbH) offering a
precision of 0.2°C and accuracy of ± 0.4°C [65]. Notably, this study did not include any
patients identified to have contracted a TKA infection.
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Further investigation added another element to the story: internal wound temperature
relative to surface skin temperature. Information on this subject is understandably limited
considering a relative lack of measurement tools for this application. One relevant study
was published in 2016 by Arjun Chanmugam et al. investigating deep wound temperature
relative to skin surface temperature. Although based on a small sample size (just 6
patients), their metrics were very relevant to the proposed project. They used their
proprietary implementation of Long Wave Infrared Thermography to image temperatures
both at skin surface and at the wound bed depth. In their control patients without
infection, they observed a gradient of 1.1–1.2°C from wound bed to surface while
infected patients showed a much larger 4–5°C gradient. Another important finding in this
study observed wound temperature changes in correlation with different stages of
infection treatment [66]. Although it is difficult to draw firm conclusions from a small
cohort study, it shows optimism that the stimulus at wound bed might be far more
dramatic than at the skin surface and that with measuring at the infection site, infection
correlation over time is feasible with implantable device.
Ultimately, the existing literature reveals that there are many reasons a patient’s mean
temperature may have a different baseline from another’s. Fortunately, the strength of a
logging platform is to characterize trended changes over time. Therefore, although
accuracy is still a valuable metric, the top priority was a high precision sensor to track
changes with reliability. After an evaluation of the related hardware and this rough idea
of the ranges to expect, the following design constraints were selected based on the above
literature: an accuracy of ≤ ± 0.5°C, a precision of ≤ 0.2°C, and a resolution of < 0.1°C
over a 35–40°C expected dynamic range. These constraints should well equip the implant
to measure the patterns of temperature fluctuation with ample performance to capture the
behaviour these studies suggest. While there is a challenge to decipher which biological
phenomenon is causing an observed change, data collection with this level of detail will
certainly offer a useable, first of its kind dataset to identify trends at the infection site and
hopefully isolate an infection correlation during patient trials. Simply, if there is a
statistical relationship to be found between temperature over time and infection status, a
device meeting these constraints should be suitable to capture the required data.
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The design decision was further limited by a need for small overall footprint. Ideally, an
implementation involving no more than the sensor itself and perhaps a 0402 size
decoupling capacitor as PCB real estate was at a premium.
Finally, power consumption was a consideration. Although the ability to “switch off” the
sensor when not in use alleviated most energy consumption concerns, there was still an
objective to reduce the amount of draw in use and while dormant.

Concept Generation, Selection & Implementation
Although many sensors were considered for this application, the following three were
identified as plausible candidates:
1) Microchip Technologies MCP9808
This I2C temperature sensor is a staple enthusiast and commercial choice for many
applications. Over the 35–40°C sensing range it reports a typical accuracy of just ±
0.25°C ranging to a maximum of ± 0.5°C. The MCP9808 is precise to 0.0625°C. It
consumes 200 µA in use and 0.1 µA in shutdown state [67].
2) Texas Instruments TMP235A2DCKR
The TMP235 series chip leverages current flow changes in thermal diodes to output an
analog signal, this can be correlated to temperature. Although at first glance, it reports an
unsuitable maximum accuracy of ± 2.5°C (typically ± 0.5°C), this is over its very large
(-40–150°C) dynamic range. A graph in Section 6.6 of the data sheet shows that accuracy
within the 35–40°C range is < ± 0.5°C with > 99% confidence. This device outputs an
analog signal, meaning a resolution only limited by the selected MCU’s ample 12-bit
ADC. Precision was not reported, but empirically found to be < 0.1°C with a five sample
windowed average. It draws just 9 µA in operation and a does not require power while
dormant. The optimal layout was determined to require just 1 decoupling capacitor for
problem free operation [68]
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3) Texas Instruments TMP117MAIDRV
This TI module is impressive in several ways. It is similar in operation to the MCP9808
above with the I2C interface but advertises superior performance. The data sheet suggests
an impressive ± 0.1°C accuracy in the operative range. The reported precision is tighter at
< 0.01°C. Active power consumption is also very low at 3.5 µA with the caveat of a slow
conversion cycle of 1 second per reading. Unfortunately, several peripheral components
are required (pullup resistors and decoupling capacitors) to implement this device
properly [69].
As these devices were all < $3 USD, several samples of each were purchased for a
benchtop evaluation selection strategy.
It was clear that although the MCP9808 and TMP117MAIDRV chips offered impressive
performance, there were challenges to their implementation. First, they both relied on a
“thermal pad” being soldered to the PCB rather than heating through the die jacket.
Therefore, if the engineer desires environmental temperature sensing, these are best laid
out on a PCB away from other components that generate heat. Unfortunately, in this case
the system’s processor is located on the opposite side of the PCB and their footprints are
superimposed. This raised concerns of the package reading the MCU heat rather than
sensing environmental stimulus.
Another concern was the number of peripheral components required for their operation.
The MCP9808 for example required 4–6 peripheral pullup resistors and decoupling
capacitors for full functionality with acceptable noise levels. With circuit board real
estate at a premium this was disadvantageous.
The TI TMP117MAIDRV platform came with the additional challenge of “blind” pins.
When soldering the chip down, the pads were not accessible to a soldering iron and a heat
soaking (hot air or hot plate) approach was required. While manageable in a single layer
configuration, this was difficult to manufacture in-house as the MCU was already a blind
soldering operation on the opposite side so uniform hot plate soldering was not feasible.
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In an application where space was not at such a premium and the sensors could be located
on the same side of the PCB as the microcontroller, the design decision may have been
different.
The TMP235DCKR option was ultimately selected. While the theoretical performance
was inferior to the other two options, following a rigorous evaluation (detailed in Section
3.2.4.1) it still satisfied all design constraints. Additionally, it was highly power efficient,
was implementable with just one peripheral capacitor, and paired well with the rest of the
embedded system layout.
Once the components to be used were selected, the team was able to calculate the power
requirements for sustained operation of the sensor. The design process for this step, in
addition to the safety considerations are discussed in Section 2.4.

Power Management, Source, and Safety
Supplying power to an implantable device in a way that is likely to be approved for use in
humans is challenging. To accomplish this task, four basic mechanisms were considered.
Energy harvesting is a newer concept to consider in the context of compact devices.
Essentially, this involves a compact generator that operates on energy already being
wasted in the environment of the device [70]. A common example would be an automatic
wristwatch that uses a rotor actuated by gravity and the kinetic force from the wearer’s
everyday movements to wind a mainspring. It is somewhat less popular in compact
electronic devices as the rate of power generation is low and the engineer still usually
requires a component to store the electricity once generated (a capacitor or battery).
There are some innovators launching a wearable device that utilizes energy harvesting in
a smartwatch application, this example runs on thermoelectric power. Unfortunately, it is
not currently feasible to simply buy a suitable energy harvesting mechanism off the shelf
[71].
Wireless charging has become a commercially available choice for developers of
compact electronics. While still relatively new in mainstream consumer electronics, it has
been applied in niche or research applications since the late 1800s where it was first
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patented as a mechanism of powering electric rail cars [72]. It operates via an inductive
coupling. At a fundamental level, alternating current is applied to a master coil by an
external power supply, by Oersted’s Law this generates an oscillating electromagnetic
field [73]. This electromagnetic field interferes with a slave coil and by Faraday’s Law
the electromotive force drives electron flow on the device end [74]. This must then be
rectified into a direct current and regulated to the appropriate voltage. When tuned
appropriately, there is no longer a need for a large power reservoir on the receiving end
of the inductive coupling, generally a capacitive storage solution is suitable provided the
inductive coupling is always present during operation. Recalling Section 2.1, this is the
option leveraged by both D’Lima and Orthoload in their instrumented implants.
However, there are challenges. An internal rectifier/regulator circuit and coil take up a
substantial amount of room and the transmission can be easily impeded by metallic
objects. When applying an inductive system, the developer risks heating up his or her
device if it is electrically conductive [75]. In the context of this temperature sensitive
device this poses a great challenge.
The third option is to implant a battery. While by far away the simplest to implement, this
has drawbacks as well. Batteries considered suitable for implantation have changed over
time. The earliest battery powered implants were pacemakers, health regulators accepted
more risk as they were a completely necessary device [76]. The chance of mercury-zinc
batteries leaking or shorting over an extended period was preferable to an imminent heart
failure. Now, medical battery safety is regulated in part by manufacturing guidelines in
ISO 13485 and is required to demonstrate hermeticity. From an electrical/chemical safety
standpoint ANSI/AAMEI ED 60601-1 depicts risk management strategies needed for
medical power supplies and IEC 60086-4 / IEC 62133 cover battery
safety/implementation for various chemistries [77]. Essentially there are four components
to a successful implanted battery: manufacturing, chemistry, quality assurance, and
implementation. These topics will be revisited in the following section.
In direct relation to the previous technology, the final concept involves coupling a
wireless charging device with a rechargeable implantable battery. Recharging of batteries
does add some (manageable) implementation challenges as accidental overcharging can
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cause a casing rupture in addition to the usual short circuit risks [78]. It would also add
substantial complexity and cost to the overall device. Truthfully, the biggest deterrent is
the dependence on patient adherence to recharge the implant regularly.
In this design context, it became clear that a primary (non-rechargeable) battery was the
optimal solution. It has strength in simplicity, and this project intrinsically has elements
making a primary battery an easy choice. First, the implant is inherently temporary. As
the sensing package is embedded in a knee spacer, it will not be left in the patient for
more than 6–10 weeks before revision to the permanent knee. The power consumption of
the electrical components selected are well known and straightforward calculations could
be performed to select a suitable capacity. With the obvious goals to reduce complexity,
size, and cost, the primary battery became further attractive. Inductive couplings as used
by Orthoload and D’Lima were completely infeasible for this usage case because they
were only suitable for taking measurements while the patient was in the lab coupled to
the master coil and this device must passively collect information for weeks at a time.
Ultimately, the biggest motivation for the primary cell implementation was complete
autonomy from patient adherence issues. As envisioned, the patient should not even have
to think about their instrumented knee spacer for the 6–10 week duration of implantation.

Concept Generation, Selection & Implementation
This team was uninterested in creating a custom battery due to the regulatory concerns.
Due to the already expansive scope of this project, it made logistical sense to outsource
the battery development. Several companies were consulted to better understand
available options for the optimal solution.
1) Integer/Electrochem
Electrochem is a battery manufacturer that sells specialized cells for a variety of
applications. They offer several different battery chemistries, and one huge advantage of
their product is that they can provide integrated undervoltage protection, saving PCB
space. Unfortunately, their catalogue offerings for implants are only approved for usage
up to 60°C. While this is acceptable in use, during the setting process of bone cement
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internal temperatures are expected to reach approximately 80–86°C so implantation
would be infeasible [79] [80].
2) Eagle Picher
This company is one of the better established in the industry. They were notable for a few
reasons. Their customer service was quick and extremely knowledgeable. When
contacted, they provided access to one of their engineers free of charge to discuss options
and offer more information than was available on their data sheets. Notably they offer
batteries in a variety of chemistries, with several options of regulatory rigour for various
applications.
3) Tadiran Batteries
Tadiran is a prominent manufacturer of lithium thyonil chloride batteries, specifically
designed for high temperature implantable use [81]. Their designs and testing procedures
conform to regulatory requirements in many regions of the world for implant safety [82].
When contacted they were also quite responsive, knowledgeable, and eager to help.
Electrochem was eliminated at a preliminary stage as none of their offerings were
suitable to withstand the temperatures required or offered appropriate capacity in an
acceptable form factor for this application.
Quickly this team narrowed down the desired chemistry to lithium thionyl chloride
(LTC). Of the battery types suitable for this environment and regulatory requirements,
these were the highest power density offerings available [83].
These can be a volatile type of primary battery and are generally avoided for consumer
electronics, but manufacturers like Tadiran and Eagle Picher have invested significant
R&D to design casings suitable for regulatory approval [82].
Unfortunately, there are still drawbacks. Any device undergoing rigorous regulatory
approval is quite expensive, the selected model for example was quoted at $250 USD
with a minimum $5000 USD order. Also, as of yet, the smallest capacity offered by either
manufacturer was 350mAh in this chemistry, roughly twice the capacity required for an
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acceptable operational lifetime including a healthy factor of safety for this specific
device. Higher capacity translates to a higher casing size and the overall implant package
is heavily impacted by the battery geometry.
Ultimately an Eagle Picher 3PN-LTC-M1 implantable class battery was selected. Eagle
Picher offers this battery with a preferable casing geometry over Tadiran for project
needs and were excellent to work with throughout the development process. They offered
a nearly identical battery, the 3PN-LTC-S2, which shares most specifications with the
medical variant but lacks the rigorous regulatory approvals. This was instrumental for
developing a minimum viable product as each battery cost only $16 USD but are a plug
and play substitute for the $250 USD medically approved sibling. Eagle Picher is also a
manufacturer of custom sized batteries. In the future if this sensing package requires a
smaller custom battery or one of a different geometry for placement somewhere else in
the body, Eagle Picher would be an excellent partner to collaborate with.
By selecting a battery that already satisfies the design, manufacturing, and quality
assurance stipulations over something like a common coin cell, a great deal of
engineering/testing responsibility was mitigated. The only component left to the design
team was appropriate implementation.
The primary concern for battery safety in any device is rupture. Rupture is generally
accompanied by explosion, venting or leakage, these are all generally undesirable. There
are four main ways to cause these problems: a mechanical interference
(crushing/piercing), over charging, over discharging, or overheating [84].
Mechanical interferences will be discussed in subsequent sections, while over charging is
not a concern for non rechargeable batteries. Overheating and over discharge protection
however, were both taken extremely seriously during implementation.
The selected batteries are suitable for temperatures up to 95°C so the casting procedure of
the bone cement is of no concern with ~10°C of headroom [79] [80] [85]. The real
concern comes from short circuiting. One common mechanism of protection from short
circuits or other sources of rapid current discharge are polymeric positive temperature
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coefficient (PPTC) devices. These are compact, self resetting fuses that operate as a tiny
thermostat. If installed in series with the battery they reach a threshold temperature either
by a high current throughput or environmental heating condition they will open the
circuit [86]. A surface mount PPTC was selected for use in redundancy to existing
overheating protection fail-safes offered by the CC2650 processor and battery
management hardware commonly integrated into the casings of medical grade LTC
batteries. Note that self resetting functionality was critical as the 80–86 °C setting
temperature of antibiotic bone cement is likely to trip many current threshold thermal
fuses that are otherwise suitable for this application [79] [80]. When temperatures return
to normal levels the circuit will reactivate.
Over discharge protection is commonly designed with an all in one “low voltage cut-off”
device coupled with a transistor to disconnect the battery when the voltage drops below
the desired threshold and two resistors to tune the boundaries of cut-off hysteresis [87].
This strategy was suggested for the final design in redundancy with the existing
undervoltage cut-off integrated into to the CC2650 programming. This redundancy was
especially critical as the FDA critically evaluated a Medtronic implantable device’s
ability to create an open its circuit during undervoltage conditions [88]. The final
electrical schematic for the device is seen in Figure 2.4 below.

Figure 2.4—Schematic of the custom printed circuit board layout which depicts the
battery, short circuit/undervoltage protection, sensor and microcontroller with
integrated antenna.
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Following the development of the circuit, shown finalized in Figure 2.4, custom boards
were printed and assembly/testing could begin. Simultaneously a discussion of
encapsulation was also underway as the final geometry of the electronics was at this stage
better understood. Section 2.5 details how this process was conducted. A completed
example of the electronics package can be seen below in 2.5.7 (Figure 2.6).

Encapsulation Strategy
Encapsulation of implantable electronics is a complex topic requiring consideration from
several different perspectives. High level strategy is discussed in Section 2.5.1, while the
nuances of functionality, safety and assembly technique are covered in the remainder of
Chapter 2.

Hermetic, Near-Hermetic & Non-Hermetic Implant Packaging
When encapsulating medical devices there are three predominant strategies: hermetic,
near-hermetic, and non-hermetic.
The classical definition of the term “hermetic” is thousands of years old, simply meaning
“airtight” [89]. However, for a device to be considered “hermetic” by United States FDA
standards, it must specifically satisfy MIL-STD-883 TM 1014 [90]. This evaluation
involves extended exposure to high pressure helium followed by an observation period in
a mass spectrometer under vacuum, which measures the leakage rate of helium
previously forced into the package [91].
Usually, devices satisfying these requirements must be designed for simple parting lines
with fused seams rather than a mechanical mate. Metallic casings are most common,
while several strategies are applied for sealing. It has been preferred to avoid adhesives
when sealing a device hermetically and rather fuse the casing together through a
technique like electron beam, laser or friction welding. Although, interest in alternatives
has been growing [92] [93]. Recently ceramics and polymers have also garnered interest
as viable possibilities for hermetic casings. The Orthoload instrumented tibial component
is a classical example of a hermetic casing. Their sealed housing is machined in three
titanium components, the electronics are placed inside, the housing is electron beam and
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laser welded together before being tested for hermeticity, calibrated, and sterilized using
ethylene oxide (ETO) [94].
At the opposite end of the spectrum are completely non-hermetic encapsulants. These are
epoxy resins or silicones designed to permit a degree of liquid ingress. They use an
entirely different mechanism to protect the circuitry from the body and vice versa. Where
the hermetic seal operates by completely isolating the inside of the casing from the
outside, non-hermetic encapsulants simply conform very aggressively to the surface of
the internals, allowing no air pockets to form between the surface of the electronics and
the encapsulant. Although the encapsulant may be saturated with bodily fluids, short
circuiting, corrosion or mixing with any contaminants cannot occur as there is no air
volume for the fluids to condense within [95]. This strategy is advantageous in
circumstances where the operation of the proposed device requires sampling of bodily
fluids.
Considering most hermetic casings are made of titanium or 316 stainless steel, many of
those devices require metal-on-glass feedthroughs and a secondary encapsulation
mechanism for an antenna, which adds complexity and cost [96]. With most nonhermetic encapsulants, wireless transmission is unimpeded thus greatly simplifying
design [97]. One drawback to consider is that any batteries would still need to be
hermetically sealed before the overall device was encapsulated non-hermetically or an
external excitation mechanism could be used.
A gastrointestinal stimulator designed by Laurent Lonys et al. in 2015 is a prime example
of an implantable embedded system. It was designed to help manage obesity by
leveraging non-hermetic encapsulant. They published an interesting article on the design
challenges of encapsulation in a highly acidic environment and why their externally
powered silicone encapsulated solution was well suited to the application [98].
Somewhere between the two other strategies falls near-hermetic encapsulation. Although
just beginning to gain momentum, there is high potential in this space for innovative
encapsulation strategies to emerge. A wide variety of materials can be considered for a
near-hermetic package. These are generally categorized with the understanding that there
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is some inherent material porosity. This disqualifies them for hermetic status as defined
by MIL-STD-883. Many would still prevent meaningful amounts of water ingress for
months or years when submerged [99]. Furthermore, some non-metallic materials that
would make eligible capsule options such as reinforced polyether-ether ketone (PEEK) or
ultra high molecular weight polyethylene (UHMW), have excellent mechanical properties
for loadbearing orthopaedic applications and RF transmission [97] [100]. Unfortunately,
at this time there is no evidence of FDA approval or in vivo studies of electronics
packaged near-hermetically.

Additive & Subtractive Manufacturing of Case Materials
For reasons discussed in Section 2.5.7, ultimately a solid external casing, hermetic or
otherwise, would be required. There are very few ISO 13485 approved manufacturing
facilities available for contract prototyping in this space, which somewhat restricted
materials, methods, and geometries to options they were able to provide.
Additive manufacturing methods (3D Printing) generally offer looser tolerances, reduced
material selection, and increased surface roughness relative to a subtractive method like
CNC machining or turning. However, they also have the advantage of generally lower
cost for small scale production and complex geometries can be more easily created
without the need for custom fixturing or 4–6 axis milling operations [101]. ADEISS, an
ISO 13485 additive manufacturing facility is local to Western University so there was
incentive to design a solution compatible with their manufacturing capabilities as this
logistically simplified the potentially iterative design process.
ADEISS offers 3D printed Ti6Al4V ELI-0406. This is a titanium alloy specifically
designed to produce excellent biocompatibility results for implantable applications and is
highly thermally conductive (6–8 W/mK), which was preferred over some of the
previously considered PEEK options for this temperature sensing application [102].
Using a 3D printing methodology also permitted straightforward texturing of the external
faces to promote bone cement integration without intensive milling operations. The only
serious concern was the challenge titanium alloy raised for RF penetration. With
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relatively high confidence in the use of this casing strategy for structural protection, a
compatible electrical encapsulation strategy was investigated next.

Conformal Encapsulant
As discussed previously, there are silicone options for encapsulation that conform
aggressively to PCBs and prevent moisture from condensing on the internal components.
There are a number of these options manufactured by several mainstream companies
suitable for implantation such as Elkem’s Silbione line, Dow Corning’s Silastic MDX44210, and NuSil’s Avantor lineup [103] [104] [105]. These products are generally
designed to be poured into a captive volume and cured under vacuum or injection molded
although some sprayable options are also available.
One other notable technology is Parylene deposition. Parylene is a generic name for a
series of polymers based on paraxylene. Parylene C coatings are prolific in the protection
of circuit boards in high risk environments. There are several FDA approved implantable
devices leveraging the protective properties of Parylene C coatings to derive their
hermeticity [106]. It appears much like a thin acrylic coating on the PCB but the
application process is drastically different (and its primary disadvantage). Parylene
requires a vapour deposition process. The parylene dimer is heated to 100–150°C under
vacuum. This extracts the vapour. This vapour is drawn through a furnace to split the
molecules into monomers. In the coating chamber (at ambient temperature) the vaporous
components rapidly seek a substrate to condense on the PCB, which causes aggressive
conformity to the circuit board components. Finally, the coating chamber is rapidly
cooled to remove any residual vaporous parylene and evacuated to a “cold trap” at -90–120°C [107]. There were two major issues with parylene coatings for this application.
The first was cost and the second was the limitation it put on future sensing options. As
parylene is a hermetic coating, it would not allow sampling of any fluidic properties.
While this is acceptable for the current temperature sensing embodiment, it could limit
future options.
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Bone Cement & Potting Considerations
Other aspects of this solution to consider were three design elements that might be
impacted by the cement potting process of this device:
1) Slip conditions and stresses at capsule/cement interface
Bone cement relies on a mechanical interlock at a micro scale rather than adhesive
properties to anchor orthopaedic components [79]. There is extensive and conflicting
literature examining various implant surface features and the relationship to PMMA bone
cement adhesion. Some suggest that beginning with a smooth surface and subjecting it to
an acidic passivation process provides superior locking to roughened surfaces as they
found air pockets more likely to form between PMMA and rough features [108]. Another
study showed that the preparation and contaminant removal on the implant surface is
more critical than any surface features [109]. A more recent study shows that a laser
peening process to produce roughened grooves significantly increased bone cement
adhesion to titanium alloys [110]. Ultimately, it was likely that implant surface geometry
would have an impact on the adhesion of the bone cement to the implant, although it was
not obvious which surface characteristics would be optimal. It became a constraint to
select a material/manufacturing process permitting flexibility in surface condition so this
could be easily iterated upon if needed.
2) Elevated cure temperature
Depending on the source, bone cement is expected to heat to 80–86°C during the curing
process that occurs during implantation [79] [80]. This constrains allowable materials to
ones unlikely to deform at temperatures in this range.
3) Fluidic penetration
PMMA bone cement is intended to completely envelop this implanted sensing package.
Over the length of this implant’s lifespan, bone cement is suitably resistant to fluidic
absorption, so no bodily fluids should ever reach the implant package [111]. Efforts
invested in designing a package to be hermetic, near-hermetic or conformal non-hermetic
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were likely to be redundant design choices. Regardless, the plausibility of error during
installation or PMMA fracture in vivo and the objective to reduce any doubts of safety
were strong motivations to constrain the material selection process to solutions offering
one of these types of encapsulation.

Thermal Insulation of the Sensor
On a separate, but tangentially related thought, a common question received throughout
the design process regarded the amount of thermal insulation the package is expected to
impart. There was an objective to have the sensor operate with minimal thermal
impedance and therefore react quickly to any changes of joint temperature. This was
impacted by the geometry and materials selected. However, this objective took relatively
low priority for three reasons. First, soft tissues and skin surrounding the joint offer
insulation, thermally stabilizing the sensing region, although it is difficult to determine by
how much. Second, this device does not require the acquisition time of a usual medical
thermometer. This device is meant to log slow changes to mean temperature over weeks
at a time. If this capsule were to filter out short fluctuations due to increased friction
while the patient ascends stairs or walks in the cold air from their car to the entrance of a
shopping mall, it was of little concern. Finally, any efforts taken to assemble a capsule
with high thermal conductivity would be stifled by the poor thermal conductivity (0.19 –
0.24 W/mK) of the PMMA bone cement mantle. For reference, the titanium commonly
used in implants is approximately 100 times more thermally conductive than bone cement
at 21.9W/mK [112].

Kinematic Loading Expectations
Another area that was originally a major design concern surrounded the effective elastic
modulus of the overall package and how it would interact with the bone cement under
loading.
A core more resistant to deformation than the surrounding bone cement could cause
delamination of the bone cement from the surface of the package and accelerate fatigue
failure of the PMMA.
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On the other hand, a core much more deformable than the PMMA could result in overall
loss of mechanical integrity of the keel component as thin walled features attempted to
withstand loads formerly supported by a much larger cross section.
Another issue was providing the appropriate cross-sectional area on the implant casing to
support the loading without piercing the PMMA. Initially, finite element analysis (FEA)
was discussed to determine how sensitive the structural integrity of the overall keel
components would be to changes in geometry and tensile moduli but finding appropriate
boundary conditions proved difficult. It was not clear how much axial loading, initially
the primary mode of concern, to expect on the bone cement spacer keel. There have been
studies on TKA stress shielding and discussions on primary TKA keel/bone interaction
but they indicate that keel length outweighs material considerations anyway [113]. There
was also extensive information on how the tibial tray component and the femoral bearing
surfaces interact as this research was the output of the D’Lima and Orthoload research
[55] [114]. Little comprehensive evidence was found on force absorbed by the planed
tibial/femoral surfaces vs. transferred loading to interfering surfaces in the intermedullary
canal.
Ultimately, an orthopaedic surgeon was consulted. It was determined that the region of
the spacer keels containing the sensing packages were unlikely to experience any
significant axial loading. There are two reasons for this. The keel of a knee spacer is
designed to prevent implant movement about the plane of the articular surface. They
anchor the TKA components against sliding transversally rather than absorbing
significant axial load, which is instead absorbed by the tibial tray/femoral condyle
interface planed perpendicular to the loading. Also, when installing a spacer, the
physician avoids packing the intermedullary canal as tightly as a TKA in anticipation of
having to remove the spacer a few weeks later. This puts the spacer at greater risk of
implant loosening, but this is preferable to difficult extraction procedure when revising to
the second TKA and consequently removes most of the material needed to cause any keel
loading. A suggestion from this discussion was to focus on avoiding features that might
increase the likelihood of the keels separating from the pre-formed articulating
components under (the more significant) torsional/transverse loading. A 2014 study by S.
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Garcia David et al. supports this anecdote through FEA of a primary TKA with a winged
keel [115]. With transverse loading of the keel identified as the more pressing concern
than axial, the objective to select a material/geometry less likely to result in keel
separation.
Another concern involved the spacer extraction procedure specifically. Extraction of a
total knee spacer can appear much like carpentry. The consulting surgeon suggested
selection of a casing likely to withstand a violent extraction, specifically to protect the
battery from becoming ruptured.

Concept Selection & Implementation
As seen from the widely variable discussions featured in Sections 2.5.1–2.5.6, the
selection of an encapsulation strategy is a complex decision. Accordingly, an engineering
design process was required to select an optimal solution.
To begin, a list of objectives and constraints were generated to discern a preferred
solution. Recall, constraints are stipulations that must be met for the project to be a
success. Objectives are criteria differentiating an optimal solution from a selection of
options that have already satisfied the constraints.
There are five constraints identified from the above investigation:
1) The encapsulation strategy must isolate the body from potential contaminants.
2) It must protect electrical components from bodily fluids.
3) The package materials must be compatible with a sterilization method adopted by
other FDA approved implants like ethylene oxide, radiation or autoclaving.
4) All components of the package must be protected from physical or thermal
damage. This is especially relevant to the installation and removal of the implant.
5) Although Bluetooth compatibility is not a requirement, the capsule must permit
some form of wireless communication to be acceptable.

45

Additionally, nine objectives were selected to derive the best solution possible:
1) The design should permit straightforward iteration to allow an easy pivot if issues
were observed with the first attempt. This was of extremely high importance as
there were many questions that could only be answered experimentally.
2) It would ideally accept alternative sensing modalities besides temperature with
ease. This was of medium importance as although future applications for this
device were envisioned, it was not pivotal to the success of this thesis project.
3) The overall design and manufacturing strategy should aim to reduce project costs
if possible. While important for a commercial product, at the prototype phase, low
cost was more of an advantage than a necessity.
4) Ideally the selected design would permit Bluetooth communication as this is the
preferred wireless communication strategy. The circuitry and programming had
already been designed/manufactured by this stage, switching communication
strategies would have been a major inconvenience so this was a high priority
objective.
5) The materials, manufacturing, and sterilization method suggested should not be
novel to the medical implant space to streamline the regulatory process. There
was a goal to have the proposed design backed up by precedent. While not
essential for a functioning solution as unconventional projects do sometimes
succeed, it was extremely advantageous to avoid this.
6) The design chosen should offer a clear, streamlined, pathway to a functioning
minimum viable product. This project had an 18 month design runway from
ideation to validation, which did not permit extended lead time for specialized
manufacturing. This was high priority for project success.
7) The materials selected and overall geometry should ideally provide relatively fast
thermal response to changing conditions. Although certainly a positive quality, for
the reasoning discussed previously, this was not a high priority objective.
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8) The capsule design should avoid the possibility of keel separation from the tibial
tray or femoral condylar geometry. While most envisioned solutions would not
compromise this junction, it was still important to device success. Note that even
passive spacers do fail at this junction without catastrophic consequence, but it is
still to be avoided.
9) There was a goal to design this device to use readily available materials and
processes to avoid a production bottleneck. Although, for testing purposes a
similar material could be used without dire concern.
With these in mind, several potential solutions were generated:
1) Hermetic titanium unibody with pass though design
This design is most analogous to other commercial devices like pacemakers. It would
consist of the electronics being secured inside a hermetic titanium enclosure made of two
parts electron beam welded together. It would require a passthrough and external cap
somehow adhered to route the antenna.
2) Non hermetic, windowed titanium superstructure with silicone encapsulant
Without dependence on a hermetic seal, this device would not be a conventional
“capsule” and would not require helium leak testing. A titanium shroud could be locally
3D printed and used to a) protect the silicone encapsulated circuitry inside from
installation/extraction procedures and b) to support the implant/PMMA interface.
Windows in the superstructure would permit a variety of radiofrequency transmission
modalities.
3) Near hermetic, carbon fiber reinforced PEEK capsule
This concept follows the work of Nathaniel Dahan et al. who showed the viability for a
PEEK capsule for short term implantable devices [92]. This capsule would be a two-piece
design that threads together before sealing by a thermal plastic weld. This material would
provide easy RF transmission and has excellent mechanical properties for the reduction
of stress shielding.
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4) Near hermetic, titanium superstructure with polyethylene cap
The final generated concept involves a titanium superstructure similar to the second
concept, but instead of relying on silicone for a non-hermetic conformal coating, it would
incorporate a polyethylene (or similar material) cap. This would retain the compact
titanium superstructure while avoiding the additional complication of a passthrough and
an electron beam welding process. However, it does raise its own concerns in lacking
precedent and a challenging sealing process.
First, the generated concepts were compared against the design constraints in a go/no-go
screening seen in Table 2.2. Any solutions that did not pass all constraints would not be
eligible for consideration as they would fail to solve the problem.
Table 2.2—Go/No-Go screening of encapsulation strategies. This is an engineering
selection tool used to filter potential solutions.
Hermetic
Capsule

Non-Hermetic
Superstructure w/
Silicone

Near
Hermetic
PEEK
Capsule

Near
Hermetic
Ti/Polymer

Demonstrated ability to
isolate the body from
contaminants

Go

Go

Go

No Go

Protect electrical
components from fluids

Go

Go

Go

Go

Compatible materials for
an FDA approved
sterilization method

Go

Go

Go

Go

Protect internals from
physical/thermal
damage

Go

Go

Go

Go

Permit some wireless
communication

Go

Go

Go

Go

Result:

Pass

Pass

Pass

Fail
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Seeing three viable options, the objectives were assigned a relative weight out of 1–3
with 1 being a “low priority” objective and 3 being a “top priority”. In an engineering
decision matrix (Table 2.3) each solution’s ability to meet the objectives was also ranked
from 1–3.
Table 2.3—Engineering decision matrix for optimal encapsulation strategy. This is a
secondary design tool to select the optimal solution from a list of feasible ones.
Hermetic
Capsule

Non-Hermetic
Superstructure
w/ Silicone

Near
Hermetic
PEEK
Capsule

3

1

3

3

2

2

3

3

1

1

2

2

3

3

3

3

3

3

2

1

3

1

3

2

1

2

2

1

3

2

2

2

2

2
41

3
55

1
45

Objective
Weight
Permit
straightforward
design iteration
Afford future
flexibility to
alternate sensing
modalities
Reduce costs
Permit Bluetooth
communication
Supported by
regulatory
precedent
Reduce time to
minimum viable
product
Permit faster
thermal sensing
response
Avoid features that
increase the
likelihood of keel
separation
Be manufacturable
through readily
available materials
Score:

Near
Hermetic
Ti/Polymer

49

Following this investigation, it was clear that the optimal solution was the non hermetic
option utilizing a titanium superstructure and silicone conformal coating/suspension. One
takeaway was that several other strategies could have also been feasible in other
circumstances. Access to the materials/equipment locally with ADEISS and previous inhouse medical silicone molding projects made the selected solution ideal for a rapid
turnaround time.
In implementation, the design began by considering the geometry of the circuitry and
battery. It was desirable to maintain at least 1 mm of silicone on all sides to account for
any assembly misalignment as it would be unacceptable to have the circuit board short
against the conductive casing. Then, after the internal geometry of the casing was
determined, several variations were manufactured, and a wall thickness was chosen
offering a good balance of deformation resistance, reduction in volume, and permitted
experimentation with various textures to improve PMMA integration. Leveraging the
capabilities of additive manufacturing, an initial surface geometry was chosen that offers
many micro dimples for the PMMA to purchase with no sharp corners, which might
prevent stress raisers and avoid premature fracture and a completely smooth alternative,
seen below in Figure 2.5.

Figure 2.5—Two titanium superstructures, pictured with the
intentionally textured pattern (left) and the smooth alternative
(right).
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While the regions surrounding the battery remain solid titanium, the area of the titanium
superstructure surrounding the Bluetooth antenna was designed with windows to
encourage unimpeded RF transmission.
Silastic MDX-4210 was the selected encapsulant for the minimum viable product. It is
manufactured by Dow Corning and is advertised as a short term implantable electronics
silicone encapsulant.
Assembly was an 8 step process:
1) The exterior of the titanium superstructure was masked off to prevent leakage
through the RF windows and maintain exterior cleanliness.
2) The MDX-4210 was mixed according to manufacturer’s instructions and
degassed at 710 mmHg at ~22°C for 30 minutes.
3) Approx. 5 mL of MDX-4210 was deposited into the bottom of the superstructure.
4) Using a custom fixture, the battery and circuit board were suspended centrally
within the superstructure (Figure 2.7) and the assembly was further degassed at
150 mmHg for 15 minutes to encourage silicone conformity to the lower half of
the circuitry.
5) The first silicone stage was then permitted to cure.
6) Step 2 was repeated.
7) With the circuitry partially enveloped in/supported by silicone, the suspension
fixture was removed (Figure 2.8) and a second stage of MDX-4210 was poured to
fill.
8) The assembly received a final degassing procedure at 150 mmHg for 15 minutes
before being allowed to cure thoroughly for 72 hours. Seen curing in Figure 2.9.
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Figure 2.6—Completed instrumentation package including MCU, sensor and
battery.

Figure 2.7—Custom fixture is installed,

Figure 2.8—The fixture is removed

suspending instrumentation package for

following Step 5 with the package

the first silicone stage.

suspended by cured first stage.
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Figure 2.9—Sensing packages in Step 8 of assembly depicting the second
silicone stage curing in vacuum chamber.

Figure 2.10— Depiction of the prototype encapsulated
system. The protruding wires are only for prototype
purposes and clipped before use.
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In to conclude this chapter, several key technical elements of the proposed sensing
package have been examined in the context of an engineering design process. One major
learning from this process should be to design for failure. Redundancy where feasible,
especially where safety is concerned and a clear “pivot” pathway if one component of the
technology requires iteration to avoid overhaul of the entire project. Deliberate effort to
design accordingly meant a functional prototype, closely resembling a final embodiment,
was ready for cadaveric study within 18 months of idea inception despite some technical
challenges.
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3

Chapter 3—Experimental Evaluation of Prototype

Having completed the design process and assembly of a prototype, a series of evaluations
were performed to inform the researchers of the device performance. This chapter
describes the experimental evaluation of the instrumented knee spacer prototype, specific
to temperature sensing for the application of infection monitoring in knee arthroplasty.

Introduction
Persistent infection of total knee arthroplasty is an issue resulting in serious long term
mobility challenges, exorbitant healthcare expenses, and occasionally, morbidity for
>20,000 North Americans annually [18] [24]. Primary infection management is handled
relatively well, with only 1–3% of total knee arthroplasties (TKA) requiring revision due
to infection [3] [4] [5] [21] [22] [23]. The gold standard treatment in these cases in North
America is a two-stage revision. This involves the surgical removal of the infected
implant and temporary installation of an antibiotic bone cement knee spacer for a period
of 6–10 weeks while the infection is treated. When convinced the infection is cleared, the
surgeon will perform a second procedure to remove the antibiotic spacer, remove any
necrotic tissue, and install the permanent “revision” knee replacement. Unfortunately,
this procedure has a much lower success rate with ~15% of revision patients maintaining
infection after this extremely costly procedure [6]. A strong possibility is that many of
these cases are persistent infection that were not completely cleared at the antibiotic
spacer phase before final revision was completed. Further, when considering common
evaluation methods, the most common tests for a primary infection plummet in reliability
as soon as antibiotic treatment is started, or dynamic amounts of swelling are present [35]
[36].
When a measured condition is relatively stable (pre-treatment), low frequency sampling
is acceptable. However, the two-stage revision process is turbulent for the joint space, the
trauma of surgery coupled with extensive local and systemic antibiotic or anti
inflammatory treatment results in dynamic fluctuation of common infection markers [35].
Taking temperatures, blood or serum samples only on occasion, when the patient visits
the clinic, may be insufficient to form a comprehensive picture of the infection status, and
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may contribute to the comparatively poor re-infection rate post revision. The same logic
is applied to sampling rates in other biometric tracking. Lower frequency sampling is
considered suitable to capture movement patterns of walking than a more dynamic
activity state like running [116]. Therefore, diagnostic tools for infection status
specifically designed for the dynamic nature of infection symptoms during treatment
would provide physicians with more a representative dataset to improve treatment
pathways.
Instrumented implants are devices surgically installed inside the body designed to collect
some information regarding biological or kinematic status. Many of these implants
combine instrumentation with other features such as an output transducer or wireless
transmission interface. Some examples would include a pacemaker, a gastrointestinal
stimulator, or a cardiac monitor. There has been some research performed regarding the
use of instrumented implants in orthopaedics, especially for kinematic analysis, but so far
there are no commercial products on the market [54] [55].
The proposed solution is intended to leverage low power embedded electronics to
instrument the antibiotic spacer with temperature sensing and logging capability. This
device would passively collect and store temperature readings directly from the implant
site. When the patient visits the clinic, the physician will be able to wirelessly access
logged information to observe trends in the joint space temperature over time.
Within this report, two hypotheses are tested. First, the sensing package developed will
offer sufficient sensing, power management, and communication performance to be
feasibly used for the application of infection diagnostics in a knee spacer. Second, the
integration of the proposed instrumented package within a bone cement spacer is unlikely
to cause mechanical or logistical issues during installation or use.
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Methods
Study Design
In order to test these hypotheses, this study was divided into two stages. The first
rigorously evaluated the sensing performance of the developed instrumentation package
using a custom PID controlled temperature chamber while the second stage utilized a
cadaver knee and mechanical loading apparatus to demonstrate in situ device
performance within a simulated environment.
The first components of this research were benchtop evaluations specifically tailored to
examining three parameters determined critical for device success: precision and
accuracy of sensing in addition to the overall thermal time constant. Precision and
accuracy tests were performed using paired correlative sampling against a reference
temperature sensor while subjected to identical conditions. This maintains consistency
with prior art in the temperature sensing/characterization domain [117] [118]. The
thermal time constant was evaluated using an 8L stovetop water bath.
The second components were performed in an n = 1 cadaver trial. These were binary
evaluations of three parameters. First, could the device establish successful wireless
connection to a mobile device while impeded by the knee tissues? Second, could the
implant collect and store temperature readings while the knee is subjected to anatomical
loading? Third, would the introduction of the proposed instrumentation package cause
mechanical failure of the PMMA spacer under representative loading conditions?
Telemetric packages were molded into the keels of both a tibial and femoral knee spacer
and surgically implanted to a cadaveric specimen. A kinematic force loading apparatus
was used to apply loading representative of what a PMMA spacer might be subjected to
in vivo. Concurrently, Bluetooth communications were tested, collection of data was
observed. After loading cycles were performed, the specimen was debrided to inspect for
spacer fracture, and micro CT scanned to examine the possibility of internal fracture
propagation.
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Specimen Design, Manufacture, and Inspection
3.2.2.1

Specimen A

This specimen was an unencapsulated version of the final device, electrically tethered to
a CC2650 LaunchPad (Texas Instruments, TX, USA) for power and real time data
transmission. It was capable of temperature sensing and serial transmission of
environmental conditions. The custom circuit board was printed by PCBWay (Guadong,
China), electrical components were purchased from Digikey (Digikey, MN, USA), hand
soldered/assembled in house using a WS81 soldering station (Weller, BadenWürttemberg, Germany) and generic hotplate. Functionality was verified using a
diagnostic program written in the Sensor Controller Studio (Texas Instruments, TX,
USA).

3.2.2.2

Specimen B

This device is an encapsulated version of Specimen A. This device utilized a 3D printed
Ti6Al4V ELI-0406 (Renishaw, Staffordshire, England) superstructure manufactured by
ADEISS (ADEISS, ON, Canada). This casing was designed to protect the sensing
equipment from loading or impact and to mechanically integrate with bone cement. The
circuitry was suspended in a Silastic MDX-4210 (Dow Corning, MI, USA) implant grade
silicone electrical encapsulant for contaminant separation according to manufacturer
protocols. The entire package was coated in ~5 mm of Simplex antibiotic bone cement
(Stryker, NY, USA). Assembly was performed in house. Following the assembly
operations, sensing functionality was verified as for Specimen A and tested for
waterproofing through overnight immersion. This device was designed to permit realtime temperature capture and transmission from within a package with similar thermal
insulation to an in-vivo application for characterization of a thermal time constant. A
visual representation of this variant is depicted below in Figure 3.1.
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Figure 3.1—Specimen B, an encapsulated
sensing package, which has been potted in bone
cement to demonstrate similar thermal insulation
characteristics to the implanted embodiment.

3.2.2.3

Specimens C1 & C2

The final specimens were duplicate, untethered versions of Specimen B, with the
omission of bone cement. This version was fabricated for use in the cadaveric trials and
closely represents the final embodiment of the proposed device. These specimens were
programmed to take temperature measurements at 15 second intervals. Specimens C1 and
C2 were powered by onboard 350 mAh lithium thionyl chloride batteries. The LTC-3PNS2 (Eagle Picher, OH, USA) was used for testing purposes but could be replaced by the
ISO 13485 certified variant (LTC-3PN-M1) for in vivo use. Note that due to (resolved)
software issues, a physical reset mechanism was required that protruded from the silicone
encapsulant and was clipped off prior to specimen use. At this stage, the entire device
should be compatible with ethylene oxide sterilization although it was untested and
unnecessary for this study [119]. Functionality was verified using a custom Bluetooth
handshaking protocol initiated from a mobile phone.
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CAD Workflow, Manufacture, and Programming
The circuitry for all specimens was laid out in EAGLE (v9.6.2, Autodesk, CA, USA).
The PCB parameters were intentionally selected for the application (dual layered, 0.4 mm
thick, FR-4, immersion gold plated contacts) and manufactured by PCBWay
(Guangdong, China).
Physical design work was performed in Solidworks (2018 & 2019, Dassault Systèmes,
Versailles, France). Solidworks was also used to mesh the STL files of the casings
provided to ADEISS (ON, Canada) for manufacturing.
Programming of the temperature controlled chamber was performed in Arduino Code
Composer (v1.8.8, Arduino, Turin, Italy). Programming of the designed implant was
performed in Code Composer Studio (v8.3.1, Texas Instruments, TX, USA) and Sensor
Controller Studio (v2.4.0.793, TX, USA).

Testing
3.2.4.1
3.2.4.1.1

Thermal and Sensing Characterization
Sensor Precision Test

To facilitate characterization of temperature sensing performance, a custom apparatus
was constructed so temperature conditions could be driven to a programmable curve over
extended periods of time. This apparatus consisted of an insulated chamber with a
resistive heating element and a sensing array of three MCP9808 automotive grade
temperature sensors (Microchip Technologies, AZ, USA). Over the relevant 35–40°C
sensing range the MCP9808 reports a typical accuracy of ± 0.25°C and a maximum ±
0.5°C. Critically, the MCP9808 is precise to 0.0625°C [67]. The system was managed by
a Feather M0 (Adafruit, NY, USA) using a custom program based on the proportional,
integral, derivative control scheme.
The temperature controlled chamber was programmed to maintain 35°C for an indefinite
period. Specimen A was suspended centrally within the chamber. After a 1 hour heat
soak, the 10 minute test was started. Sampling was performed at 200 ms intervals and
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divided into 5 sample non overlapping windows. The median of each window
represented one “reading”. The 200 ms sampling rate was chosen because this is the
intended “in use” frequency for this device. The number of samples per window is
inversely correlated to the observed precision (approaching a lower asymptote), 5 sample
windows were likely to yield acceptable (< 0.2°C) sensor precision based on similar
literature characterising temperature sensors and some preliminary evaluation [117]
[118]. The length of the test was chosen to yield > 100 independent readings affording a
95% confidence interval on the standard deviation, where standard deviation is equivalent
to sensing precision [120]. The ability to maintain a temperature inside the controlled
chamber for an indefinite period easily permitted gathering > 100,000 readings. This
allowed several repetitions of the test and experimentation with various window lengths.

3.2.4.1.2

Sensor Characterization and Accuracy Test

The second thermal test determined both the characteristic equation relating unitless
analog sensor readings to tangible values in °C and to evaluate the sensing accuracy of
Specimen A relative to a reference sensor. Specimen A was suspended centrally within
the chamber. After a 1 hour, 35°C heat soak, the test began. The chamber was
programmed to hold stable temperatures at 0.25°C increments for 10 minute periods
stepping from 35.5–40°C. The readings were captured using the same 5 sample, non
overlapping windows at 200 ms frequency. Values collected during the transient period
between temperatures were discarded to remove potential error caused by different
thermal time constants between the reference and experimental sensing boards. Thermal
rise time was characterized separately. A paired correlative sampling technique was
applied as depicted by other similar characterizations [117] [118]. The readings were
regressed against the reference sensor readings integral to the PID controlled chamber to
generate a characteristic equation. This procedure was repeated twice to provide a
“calibration” dataset and a “validation” dataset. The characteristic equation generated
from the calibration set was used to regress the validation numbers. Accordingly, the
root-mean-squared error of the validation set relative to paired correlated samples across
the entire sensing range represented the sensor accuracy. Further, hysteresis was
considered by evaluating the mean difference between samples collected at each
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temperature while the chamber was sequentially increasing in temperature versus while
the chamber was sequentially decreasing in temperature.

3.2.4.1.3

Thermal Equilibrium Test

Using an identical sampling protocol to the previous analyses, Specimen B was permitted
to thermally stabilize for a period of 5 hours at room temperature (~21°). For this test, a
large volume water bath (8L) was utilized as is common to other experiments designed to
ascertain a thermal time constant of an unknown device [121]. The water bath was heated
to a randomized temperature between 35–55°C and permitted to reach thermal
equilibrium over a 5 hour period. Data logging then began and 100 readings were taken at
room/initial temperature before submersion in the water bath. Timestamped values were
collected until readings suggested Specimen B had reached thermal equilibrium with the
water bath at the “final” temperature. This process was repeated for a total of 15 trials.
Following all trials, each dataset was normalized between 0 (initial temperature) and 1
(final temperature) before superimposition of all curves on a single plot. Finally, a
thermal rise coefficient was measured along with 95% confidence bounds. Note the
comparatively large volume water bath was assumed to be thermally unaffected by the
submersion of the cooler specimen and the submersion process was assumed to be
instantaneous as reflected in previous literature [117] [118].

3.2.4.2
3.2.4.2.1

Cadaveric Investigation
Cadaver Preparation

After a medial parapatellar arthrotomy was performed to expose the knee joint, Triathlon
(Stryker, NY, USA) instruments were utilized to perform the bone cuts. The patella was
everted, and the fat pad, ACL, PCL, and meniscus were resected. Using an
intramedullary guide, the distal femoral cut was made at 10 mm depth and at 6 degrees to
the anatomic axis. The anterior and posterior cuts based on measured resection principles
resulted in appropriate bone resections. The proximal tibial cut was made using an
extramedullary guide, at 9 mm of depth based on the lateral tibial plateau and 3 degrees
of slope.
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After checking the balance, the anterior and posterior chamfer cuts were performed.
Trialing demonstrated a balanced knee after appropriate sizing. Simplex antibiotic bone
cement (Stryker, NY, USA) was used to cement Specimens C1 and C2 into the femoral
notch and tibial intermedullary canal respectively. Preformed InterSpace (Exactech, FL,
USA) articulating spacer components were cemented in, with removal of excess cement.
Figure 3.2 shows the general location of where both sensing packages would reside in the
knee before bone cement application. Implementation seen in Figure 3.3 and Figure 3.4,
which depict the knee with the installed spacer in flexion and extension respectively.
Finally, the mid femur, mid tibia, and mid fibula were skeletonized and cemented into
polyvinyl chloride pipe for mounting to the anatomic motion simulator.

Figure 3.2—Approximate location of the Specimens C1 &
C2 within the cadaveric specimen prior to bone cement
application. The femur is above, while the tibia is below.
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Figure 3.3—Cadaveric knee featuring InterSpace
articulating components and novel instrumentation as
seen in flexion

Figure 3.4—Cadaveric knee featuring InterSpace
articulating components and novel instrumentation as
seen in extension
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3.2.4.2.2

Anatomic Loading Profile

The VIVO 6 Degree of Freedom (DoF) joint motion simulator (Advanced Medical
Technologies Inc., MA, USA) was used to apply anatomically representative loading to
the knee/spacer. The mounting and implementation can be seen below in Figure 3.5. This
device was capable of loading both the femur and tibia independently. It permitted
anatomically correct, axial tibial rotation throughout each “stride”. The system was
closed loop with forces being measured by a 6 DoF load cells attached to the tibia. Setup
of the system was performed in accordance with previous literature [122]. The selected
loading profile included reduced magnitude (~500 N) loading for 30,000 cycles, cycled at
0.5 Hz, with a 60° flexion range about the joint axis and permission for 20° rotation about
the tibia longitudinal axis.

Figure 3.5—Depiction of the cadaveric knee with the installed articulating spacer
and sensors mounted to the VIVO apparatus for the purposes of anatomic loading.
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3.2.4.2.3

Radio Frequency Penetration Check

This test was performed using both a Huawei P20 Pro (Huawei, Guangdong, China)
running Android 9.1 and a 2019 Apple iPad (Apple, CA, USA) running iOS 12.1. Both
devices were running LightBlue (Punch Through, CA, USA), a free software designed
for low level Bluetooth communication. Immediately before and after the “Cadaver
Preparation”, Bluetooth connection was established with both specimens (C1 and C2)
from a distance of 30 cm. Signal strength was recorded as reported on both mobile
devices, for both specimens, at both time points.

3.2.4.2.4

Data Collection During Anatomic Loading Check

This test was intended to demonstrate the ability of the implant to collect/transmit
meaningful data while installed in an antibiotic knee spacer being subjected to anatomical
loading. Testing was performed using a Huawei P20 Pro (Huawei, Guangdong, China)
running Android 9.1 and the LightBlue (Punch Through, CA, USA) Bluetooth sniffer.
Following the completion of the Anatomic Loading Profile, a Bluetooth connection was
established with one of the implanted specimens and commands were issued to wirelessly
offload the collected temperature readings from within the implant taken during the
loading cycle. The same procedure was attempted for Specimen C2. The values were
then exported and checked for coherency.

3.2.4.2.5

Mechanical Integrity Check

This test was intended to examine if the knee spacer demonstrated any modes of obvious
mechanical failure due to instrumentation integration. Limited literature is available on
the topic of anatomic spacer loading. Two examples used a 5000 cycle protocol with
increasing force from 400–1200 N although this protocol was designed to identify modes
of failure rather than replicate real usage to see if failure would occur [123] [124]. This
team selected an approach that might replicate real world usage. The loading profile
involved 30,000 cycles of net 500 N loading as a resultant component of force about the
medial/lateral, anterior/posterior, and vertical axes. Two stage revision patients will likely
only be walking with a walker or cane for the first 4–8 weeks following surgery, and with
limited loading for the next several weeks, hence the reduced loading profile. Patient
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activity information for the weeks immediately following knee replacement surgery is
limited, but likely to be greatly reduced [125] [126] [127]. Primary (uninfected) TKA
patients take an average of 5278 (SD 2999) steps/day preoperatively [128]. The testing
cycle count was selected to reflect a generous 25% of preoperative step rate, every day
for ~8 weeks, a reasonable amount of time to revision [129] [130].
Following the anatomical loading cycle, the cadaveric specimen was skeletonized and
visually inspected for tibial tray separation or other obvious fracture. Then both the
femoral and tibial knee regions were micro CT scanned at 154 µm resolution, 120kV tube
voltage, and 20 mA tube current. The images captured were evaluated for any internal
cracking or stress fractures around both specimens (C1 and C2). This radiographic
analysis was valuable because it is non-destructive. Observations made essentially
involve an inspection of the boundaries where the bone cement mated with the
encapsulated electronics and the bone. Telling features include voids/cracking, which are
indicated by darkened regions.
The last element of this investigation involved a manual debridement process to extract
the implants. This was undertaken after imaging with the understanding that damaging
the implanted spacer in ways additional to the intended testing was possible. It was still
valuable for visually confirming the findings from the non-destructive imaging above.

Statistical Analysis
All datum handling throughout this investigation was performed in either Excel (365 Pro
Plus, Microsoft, WA, USA) or MATLAB (v2018, MathWorks, MA, USA). The Curve
Fitting App within MATLAB was used for datum regression and prediction boundary
tabulation for all of three of the thermal and sensing characterization tests. Final plots for
presentation were generated in Prism (v8.4.2, GraphPad, CA, USA).
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Results
Specimen Manufacturing
Specimens A and B were manufactured as planned and performed as expected during
testing.
For Specimens C1 & C2, after external power wires were removed, the batteries were
installed, and communication functionality was confirmed. An issue with the ability to
wirelessly reset the device was observed. Hardware level reset was required to rectify the
issue. This resulted in the need for two wires to protrude from the silicone so the device
could be reset immediately prior to implantation during the cadaveric study.
Approximately three hours following implantation, communication was lost with C1, the
tibial sensor. Post study dissection and analysis revealed a short circuit where the
protruding hardware reset wires had permitted fluids to condense on the circuit board
surface (Figure 3.6). C2, the femoral sensor performed properly for the duration of the
test and continued to do so for several weeks following the test.

Figure 3.6—Retroactively identified oxidation
on decoupling capacitor as a result of fluidic
condensation during testing and delay before
debridement.
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Sensing Precision
The sensor precision was measured at a constant 35°C temperature using 100 consecutive
5 sample, averaged, non overlapping windows. Precision was recorded to be 0.0928°C, or
0.09°C when considering significant figures, with 95% confidence by calculating the
standard deviation of the 100 measurements captured at steady state condition.

Sensor Characterization, Sensing Accuracy & Hysteresis
Sensor characterization was performed on the calibration dataset. This equation regresses
the arbitrary units read from the experimental sensor analog output to a useful value in °C
as determined from the reference sensor’s paired correlative data points. This regression,
performed on the calibration data set, can be observed in Figure 3.7. The characteristic
equation was T[°C] = 0.3411 × Measurement – 54.55 with 0.995 R-squared correlation.
Sensor accuracy was tabulated by applying this characteristic equation to the validation
dataset and measuring the root-mean-squared error, producing ± 0.24°C accuracy with
95% confidence throughout the sensing range.

Figure 3.7—Graph depicting the comparison of the reference sensor
readings vs. the experimental sensor readings and visualization of
the characteristic equation of the calibration dataset.

Experimental Sensor Readings [C]
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Visualization of Validation Dataset
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Reference Sensor Readings [C]
Figure 3.8—A visual representation of the validation dataset.
This depicts the relationship between the experimentally
captured values regressed to degrees Celsius and their paired
samples from the reference sensor.
In Figure 3.8 the validation dataset is displayed. On the y axis are the experimental sensor
readings (as in Figure 3.7) but on the x axis the reference sensor readings have already
been converted to degrees by the characteristic equation found from the calibration.
Hysteresis was also observed in the validation data set to have a mean value of -0.001°C
across the entire 35.5–40°C sensing range with a SD of 0.007°C. Each bar on Figure 3.9
below represents the difference between the average recorded temperature while the
chamber was maintained at a given condition as the temperatures were increased, minus
the equivalent value during the descending phase of the test. Each “step” consisted of
N=350 sequential measurements. It should be noted that the largest individual hysteresis
values observed were still well within the magnitude of the previously measured
precision, so it is difficult to interpret this result as anything more than noise.
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Figure 3.9—Graphical depiction of the hysteresis observed
at each temperature step. The mean value (-0.001°C) is
displayed in blue.
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Thermal Equilibrium & Insulation
The thermal time constant of the cemented instrumentation package was measured. Note
that the thermal time constant is a measurement of time between the moment of
temperature “disturbance” (immersion in heated water bath) to when the system reaches
63.2% of the equilibrium temperature [131]. The result was τ= 262.67 ± 4.56 seconds
was determined empirically and an associated settling time of Ts= 1027.57 ± 17.84
seconds (~17 min) was tabulated assuming a lumped thermal capacitance model. Figure
3.10 below displays the repeated trials superimposed and the dotted lines highlight the
point where the thermal time constant may be measured.

Figure 3.10—Graph of "Thermal Step Response" with 15 repeated
trials of package temperature rise superimposed. Dotted lines highlight
the average amount of time required for 63.2% of rise, also known as
the thermal time constant.
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Radio Frequency Penetration
Bluetooth connection strength was evaluated for Specimen C1 and C2, using both an iPad
and Huawei P20 Pro, before and after surgical implantation. Table 3.1 displays the
recorded signal strength, noting that closer to zero is a “stronger” signal. Superior
performance was observed with the latter, but both devices were determined suitable.
Table 3.1—Bluetooth Signal Strength Before & After Implantation4
iPad

External Signal Strength (dBm)
Implanted Signal Strength (dBm)

C1
(Tibia)
-65
-97

C2
(Femur)
-60
-93

P20 Pro
C1
(Tibia)
-53
-78

C2
(Femur)
-62
-82

Data Collection During Anatomic Loading
Temperature readings captured at 15 second intervals during the anatomic loading test
were retrieved from the femoral sensor without issue following the testing. These values
can be seen depicted in Figure 3.11. As discussed in Section 3.3.3, the tibial mounted
sensor failed before the anatomic loading test began and was not collecting data.

Figure 3.11— Graph of "Temperature Readings vs. Loading
Cycles" depicting the temperature captured by the
instrumented implant throughout cyclic loading.
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Mechanical Integrity
The cadaveric knee was skeletonized following the anatomic loading profile. The
specimen, with a clear view of the articulating surfaces, can be observed in Figures 3.12
and 3.13. No indication of tibial tray, femoral keel separation or other catastrophic failure
was observed.

Figure 3.12—An axial view of the articulating
surfaces following the loading cycle and debridement.
Note excess bone cement on the tibial tray has been
worn smooth.

Figure 3.13—An auxiliary view of the tibia and femur
following the loading cycles and debridement. No
spacer separation or major fracturing was observed.
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Micro CT scans were examined for fine darkened lines propagating from the bone
cement to titanium interface to indicate stress fracturing. Although no sign of stress
fracture was found, some areas of poor bone cement integration with the textured surface
sensing package were observed. This phenomenon can be seen highlighted by yellow
circles in Figures 3.14 and 3.15.

Figure 3.14—Micro CT image depicting a region on the posterior face
of the potted sensing package in the tibia where poor bone cement
coverage is observed.
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Figure 3.15—Micro CT image depicting a sagittal view of the tibial
implant where three regions of poor bone cement integration with
the implanted instrumentation can be observed.
When examining the femoral component’s imaging results, no similar voids were
observed. These findings were corroborated by manual removal of the spacer from the
bones and conducting a visual inspection. Shown in Figures 3.16 and 3.17, there are areas
of the tibial spacer where the titanium casing can be clearly seen uncovered.
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Figure 3.16—Two areas with insufficient bone
cement can be observed on the tibial keel.

Figure 3.17—A third area with a void of bone
cement coverage on the tibial keel.
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Figure 3.18—Explanted femoral spacer component clamped in a
bench vice displaying superior bone cement coverage of the sensing
package.
Upon the completion of the extraction procedure, it was clear that the femoral component
showed far superior coating of bone cement, evident in Figure 3.18. Although not directly
visible in the above image, the PMMA mantle was approximately 5mm thick in most
places.
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Discussion
The performed testing implies an optimistic future for this novel sensing implant augment
for orthopaedic infection diagnostics. Tight sensing precision coupled with reasonable
relative accuracy and thermal capacitance revealed solid performance characteristics. The
confirmation of Bluetooth penetration through knee tissues, logging capability in situ and
the absence of any structural spacer issues under kinematic loading implies real world
feasibility for this device to be of value beyond the benchtop.
Because there are no competitive devices or true precedent in this space, it is unfair to
estimate this implant’s performance at detecting a periprosthetic joint infection without a
clinical trial. Beyond impressive sensing characteristics, there are two good indicators
that this device will be successful. First, existing diagnostic protocols already perform
well while recognizing infection at steady state, they only lose efficacy during the
dynamic infection conditions caused by treatment [35] [36]. Basic control systems theory
then indicates that existing measurement types are likely satisfactory, but lack the
appropriate sampling rate (once per clinical visit) to properly represent the true dynamic
infection status [132]. Second, even if early trials reveal that temperature sensing is not
the ideal modality, this device has been designed to accept any analog or serial interface
sensor that physically fits, so a rapid pivot would be trivial.
However, the testing was not a unilateral success. Premature failure of one sensing
package was the result of a sequence of events caused by a software issue, which required
some improvisation. Issues with wireless/software reset functionality meant a physical
switch had to protrude from the sensing capsule and clipped off before implantation. This
resulted in moisture condensation against a decoupling capacitor causing a short circuit.
With soft reset functionality rectified, the protruding wires would not have been required
and this short circuit would not have occurred. One interesting takeaway from this failure
was that the femoral component is perhaps a preferred location to embed this sensor over
the tibial spacer. The femoral notch offers space for increased cement volume relative to
the intermedullary canal of the tibia and permits a more thorough coating of the sensor
with bone cement. A likely reason the femoral sensor did not fail in the same way as the
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tibial was the more generous application of bone cement permitted by the femoral spacer
geometry, thus preventing moisture from ever reaching the sensor package.
From the testing performed, it was observed with 95% confidence that the temperature
sensing hardware was accurate to ± 0.24°C in the anticipated sensing range (relative to
reference) and precise to 0.09°C with hysteresis found effectively negligible when
compared to the precision. Accuracy is of lower priority in this context because nobody
knows the temperature threshold for “infected” vs. “healthy”, as that value may vary
from one patient to the next. Still, this accuracy is superior to some thermometers used
for assessing elevated knee temperatures post surgery [65] [133]. The high precision
sensing is the more meaningful result for this application. This indicates reliable, trended
data will be collected meaning patterns can be observed with confidence. Two studies
evaluating operative vs. non operative knee surface skin temperature found a temperature
differential of healthy patients peaking 7 days post surgery at + 2.4°C and + 2.9°C
respectively [65] [134]. Another study examined systemic effects of TKA infection and
found core temperature might increase by 1.2°C from the fever response, although
unclear what the localized response magnitude might be [135]. A fourth study
investigates the temperature of an infected wound relative to skin surface temperature and
found a gradient of 4–5°C but more critically was able to observe infections at different
stages showed that patients’ deep wound temperatures decrease by 0.8–1.1°C mean
temperature as their infections are cleared. This was measured with long wave IR
thermography [66]. Considering the proposed device demonstrated sensing precision 1–2
orders of magnitude tighter than the anticipated fluctuations, this device is suitable for its
application.
The sensing package has memory for 5500 individual temperature readings. With a goal
of a 6 week logging period before requiring a clinical visit to offload the data,
measurements can be taken at 20 minute intervals. The device’s battery life is well in
excess of any period the patient might keep their antibiotic spacer before revision so
absolutely no patient input is required for operation including charging. The thermal time
constant analysis revealed τ= 262.67 ± 4.56 seconds and an associated settling time of
Ts= 1027.57 ± 17.84 seconds (~17 min). The settling time during dynamic conditions
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being shorter than the programmed sampling rate implies that the thermal capacitance of
the encapsulation materials and bone cement is unlikely to “filter out” meaningful
patterns in temperature fluctuation.
Bluetooth penetration and signal drop when implanted was inline with literature
estimations [58]. Especially while using more recent smartphone hardware, stability was
excellent. This was ideal for commercial feasibility because Bluetooth connectivity is
native to most smartphones and a dedicated transceiver can be replaced by a simple
phone application downloaded by the physician.
The culmination of the results collected from these evaluations suggest a positive
resolution to the first hypothesis. The electronics of this package (with rectification of the
protruding wires) offer suitable characteristics for the intended usage of this device
moving forward.
Mechanical results of the test were also promising with no indication of internal stresses
or catastrophic spacer failure revealed by micro CT scans or manual debridement and
inspection. Previous literature implies that this result would be common for a patient
adhering to reduced loading guidelines. Mechanical failure of spacer components was
only prevalent in patients that disregarded instructions to avoid full loadbearing. In
patients receiving identical Exactech spacer components to ones used in this study, some
reported modes of failure include fracture of the femoral component or subluxation of the
tibial component [126]. Another study evaluated spacer performance using a very similar
apparatus to this investigation observed failure in the form of aseptic loosening or
femoral component fracture [124]. One study evaluating patients with PROSTELAC
spacers and another study cementing in explanted and sterilized knee components
observed fractures of the tibial component [136] [137]. No cases were found suggesting
that fracture of the keel components is particularly likely and the observations made in
this study do not suggest any new cause for concern caused by the inclusion of the
instrumentation package. It is worthwhile considering the superior bone cement mantle
consistency in the femoral component though. It was obvious that in the femoral
embodiment, the notch geometry offers more room, and crucially better surgeon access

81

for bone cement application than the intermedullary canal of the tibial location. Based on
the available information, especially in the femoral embodiment, the results depict an
affirmative response to the second hypothesis. This evaluation has not uncovered any
concerns of mechanical spacer failure as a result of introducing the proposed
instrumentation package.
This study does have some limitations. First, because the reference sensor was externally
validated and delivered with a calibration certification, the PID chamber was assumed to
be satisfactory when driving conditions to within the least significant digit of desired
temperature. That said, the overall apparatus was not validated externally and there is
room for fair criticism. Precision could have been measured at several different
temperatures but in this case was not. The study assumes precision to be constant
throughout the relatively small 35–40°C sensing range. Also, battery capacity was more
than satisfactory for the usage case and device lifetime is several times longer than the
implantation period, so power consumption was not prioritized as an investigation
objective, but as the device is redesigned with new (smaller) battery technology this
question becomes more important. Perhaps the largest limitation lies in the cadaveric
testing method. Due to COVID-19 challenges, the in situ tests only included one
cadaveric specimen with a total of two sensing packages installed and anatomically
loaded. While the findings were optimistic, this latter component of the study lacks the
power to draw statistical confidence in the observations and would benefit from
additional cadaveric specimens to improve this.
In conclusion, observed device performance was satisfactory relative to the application
conditions. The sensing performance regarding precision, accuracy, and thermal
insulation are suitable for the envisioned infection diagnostics application and the sensing
package appears to be capable of seamless mechanical integration with the existing two
stage total knee revision procedure. However, the inception of this device may be even
greater than the performance information presented here. Data logging and measured
decision making are already changing the cardiac field, there is hope that this device
might begin a trend of similar technology trickling into the orthopaedic field, beginning
with infection.
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4

Chapter 4—Summary, Discussion, and Conclusion

The final chapter of this thesis reflects a summary of the findings throughout this project.
Crucially, it covers some limitations observed with these evaluations and prototype.
Further, it revisits the problem definition and research questions along with a discussion
on next steps. This chapter begins with a retrospective glance at the prototype
performance.

Summary of Device Performance
As discussed in Sections 3.3 and 3.4, overall device performance is encouraging despite
the issues with prototype manufacturing. To clearly reiterate, the sensing device has
demonstrated a precision of 0.09°C, ± 0.24°C accuracy relative to reference with 95%
confidence and a characteristic equation was generated for translation of analog readings
to tangible temperatures. Note that precision is tabulated based on a 5 sample non
overlapping window while accuracy is reported through paired correlative sampling and
is therefore relative to the accuracy of the reference (MCP9808) sensor.
During the evaluation of thermal response time, a thermal time constant of τ = 262.67 ±
4.56 seconds was measured over 15 independent trials to various temperatures. This
results in a settling time of 1027.57 ± 17.84 seconds assuming lumped thermal
capacitance (discussed below in Section 4.2).
When surgically installed in a cadaveric knee, the Bluetooth signal strength was
measured before and after the procedure using both an Apple iPad and a Huawei P20 Pro
Android device. Overall, when implanted in the femoral component, an average
transmission strength drop of 26.5 dBm was observed and 28.5 dBm in the tibial
component.
Between the Bluetooth measurements and the beginning of the anatomic loading,
connection was lost with the tibial sensing package. The femoral package performed as
anticipated throughout the test and continued to operate post extraction.
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During cyclic anatomic loading, the femoral sensing package demonstrated the ability to
collect and store sensor readings at the programmed 15 second interval. Following the
test, it was able to wirelessly export the values to either the iPad or P20 Pro when given
the wireless command to do so.
Following anatomic loading, micro CT scans were taken to observe any evidence of
internal spacer fracturing, which may have been caused by the integration of the proposed
sensing package, but no damage was observed. There were some regions immediately
adjacent to the sensing packages with air pockets present. Full manual debridement of the
spacers from the knee joint following these scans revealed areas where the bone cement
was not uniformly applied around the sensing packages, but no mechanical issues were
observed as a result beyond increased fluidic exposure of the tibial sensing package.
During the manual debridement, the malfunctioning tibial sensing package was further
analyzed. An issue with the software before the test resulted in the temporary need for a
hardware level reset mechanism. As a result, two wires had to protrude from the silicone
mantle. Silicone adhesion to the wire sheathing was insufficient for moisture sealing,
coupled with inconsistent bone cement coverage of the tibial component, this permitted
fluidic penetration, which ultimately caused a short circuit. This did not result in any
battery leakage, swelling or other safety concern, only an inactive sensing board. In
future iterations, the root cause of this issue was addressed with a software revision
eliminating the need for protruding wires.
Section 4.2 is meant to contextualize some of these observations in a way that might
reflect more meaningfully on the conclusions to be drawn and the impact on research
questions.

Ramifications of Performance on Utility
Sensor accuracy was a lower priority for this application. As previously discussed in
detail, it is far more likely that infection monitoring will involve mean temperature
monitoring with no absolute thermal threshold pointing to a diagnosis. Still, it could be
convenient for future sensing applications that have not yet been identified to offer
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respectable sensing accuracy. As it stands, the accuracy measured is superior to medical
grade radio frequency thermometers used in similar literature such as the MS LT series
devices manufactured by Optris or the popular 0S530LE from OMEGA Engineering that
report ± 0.4°C and ± 0.37°C accuracy respectively at 37.0°C [65] [133].
Sensor precision was more critical. Other studies imply that over a daily period, natural
body temperature fluctuation may easily exceed 1°C [51] [64]. When examining
operative knees in general temperature increases of > 2°C [65] [134]. Deep wounds
temperatures have been correlated against infections and a thermal increase of 0.8–1.1°C
might be expected in infected patients [66]. Daily body temperature fluctuation is of no
concern, as this is easily averaged out. There is some concern that in patients, future work
might observe a mean temperature decrease and find it difficult to differentiate between
infection subsidence and the surgical healing process slowing down. It is hypothesized
that a key infection indicator separated from the natural healing process might be mean
temperature increase following the end of an antibiotic bout, implying infection
resurgence. Regardless, if there is a meaningful trend of temperature to correlate with
infection, as suggested by Chanmugam et al., the sensing precision of 0.09°C offers
suitable performance for confident capture considering the anticipated fluctuation [66].
The thermal time constant was used to tabulate a settling time of roughly 17 minutes.
Accordingly, in patient use, the sensing device will be programmed to collect a
temperature reading once every 20 minutes. This calculation was done by modelling the
system assuming lumped thermal capacitance. This methodology is common for small
solids with relatively large conducting surface area when the exact thermal properties of
the materials used are unknown. The operative feature for lumped thermal capacitance to
be valid is a Biot number ≤ 0.1. Practically speaking, thermal conduction at the surface of
the object must be 10 times (or more) greater than the convection within the object [138]
[139]. Solids, like the proposed sensing package, have effectively no internal convection
as convection requires fluidic movement. As a result, any amount of thermal conduction
at the surface of the spacer, with negligible convection, makes this device a candidate for
this representation. A critical feature of this model is that the ∆T does not matter; the
system will equilibrate in the same amount of time regardless of a 0.1°C or 10°C change.
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Accordingly, the temperature of this device may be represented by the following equation
[138].
𝑡
(𝑇(𝑡) − 𝑇𝑓 )
= 𝑒 (−𝜏)
(𝑇𝑖 − 𝑇𝑓 )

T(t) = Instrumented spacer temperature at time of interest
Tf = System final temperature
Ti = System initial temperature
t = Time elapsed since temperature change in seconds
τ = Measured thermal time constant in seconds
Note that settling time is commonly observed as the amount of time from disturbance
(temperature change) to when the system reaches, and stays within, 2% of the final value
[140].
Successful Bluetooth transmission through the knee tissues was encouraging. Although
observed signal strength drops were substantial after implantation, they were manageable.
Few, if any, mobile phones or tablets are natively equipped for low frequency
transmission, while application development and support for independent development of
Bluetooth devices is prolific. With the eligibility of Bluetooth connectivity confirmed for
this application redesign of the circuitry will not be necessary and a dedicated transceiver
device to collect information wirelessly is not required. This shortened the development
timeline and may improve adoption by healthcare practitioners if additional hardware is
unneeded.
The learnings from the cadaveric debridement and imaging process were just as valuable
as the test itself. For example, it became clear that the titanium housing designed easily
protects the circuitry within from the relatively violent extraction process. It was also
clear, both during implantation and removal, that the femoral spacer represents a far more
accessible location than the tibia for placement this sensing device for in vivo use.
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Another question regarded the surface texture of the sensing package. During
manufacturing, two surface finishes were made. One was intentionally textured to
discourage slip conditions between the package and the bone cement while the other was
relatively smooth. Recall that the previous literature comes to no clear consensus on the
topic of which is better [108] [109] [110].
For the test performed, exclusively the textured titanium samples were used. In some
cases the debridement procedure showed excellent integration. However, in other areas,
clearly adhesion was not well maintained with the observation of voids. It was clear that
the coverage of the femoral component was better than the tibial stem, the geometry of
the cavity the femoral sensor resides within lends itself to more thorough PMMA
packing. Given only a single cadaveric specimen was used, this study was unable to
investigate the integration of various titanium surface textures. This is understood as a
distinct limitation of this research but a truly rigorous evaluation on this topic could be an
independent thesis project of its own.
One regret from the study was the lack of attention to preprocessing of components
before assembly. Literature read afterwards discussed cleaning procedures with alcohols
for circuit boards prior to encapsulation [141] [142]. Other literature discusses degreasing
of metallic components prior to implantation in cemented applications [109]. It is
plausible that the electrical failure of the tibial sensor may not have occurred with better
conformal coating or more thorough PMMA encapsulation.
Another component of the manufacturing process not initially considered was the lack of
vacuum rating for the selected battery. The silicone encapsulant manufacturer’s
instructions prescribe curing under vacuum to avoid air pockets (unacceptable in this
application) [104]. The battery was not rated for vacuum. After contacting the battery
manufacturer, clearance was given to place the battery under 10 mmHg of vacuum, but
this was only a third of the recommended vacuum for the silicone. A change to the
manufacturing process involving one more curing step may be in order to ensure the
circuit board is conformally coated before battery installation.
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Limitations, Recommendations & Future Work
As highlighted by section 4.2, this study admittedly, has several limitations at a higher
level than the specific ones discussed in Section 3.4. A dedicated study to the integration
of bone cement with the instrumented package may be required if future cadaveric
specimens continue to show voiding issues. A direct limitation of the N=1 cadaveric
study is the uncertainty of how consistent this issue is. Should future cadaveric testing
reveal this problem is prolific, a dedicated examination of this phenomenon and the
solutions (textures, geometry, prep etc.) would be worthwhile. Also, while any minor
current leakage in the circuit is of no consequence in the existing application (with
surplus power reserves and a lack of regulatory oversight) this will require measurement
before human use. Along the same line of reasoning, ETO sterilization protocols would
have to be performed on the assembled device to ensure sanitation and technical
compatibility.
The insights found in Section 4.2 directly correlate to a range of discussion on which
steps could be taken going forward to improve the evidence generated, iterate and
ultimately demonstrate improvement on the suggested solution.
Work following the cadaveric study involved an immediate priority to remove the need
for a hardware reset interface. Now, the software permits a wireless command to be sent
to wipe the sensor’s onboard memory, which permits new data to be collected after
offloading the old stored data.
The circuitry was simplified for the purposes of the above studies, without the redundant
circuitry present to protect against short circuits and undervoltage cases. As it has become
clear this device has value for clinical study, the next batch of sensing packages
manufactured will be equipped with the full compliment of previously specified electrical
protection.
Although unlikely, if moisture condensation continues to be an issue after the protruding
reset wires became obsolete, revisiting an alternate generated solution for encapsulation
(Parylene C) may be considered despite the drawbacks. Contaminant isolation for the
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patient and circuit board protection are both obviously higher priority than the flexibility
to potentially add different/incompatible sensors in the future.
Ultimately the next steps for this project includes two things. First, additional cadaveric
trials will be needed to build statistical confidence in device performance and spacer
mechanical integrity once instrumented. After the findings within this thesis are
confirmed with greater confidence, a human trial will be performed in an attempt to
correlate infection status with mean internal joint temperature.
Should a temperature/infection correlation not exist, hopefully some cutting edge sensing
options such as ESR and CRP lab-on-chip devices will have migrated from research labs
into production/implementation [49] [50]. As soon as these devices are commercially
available, implementation into the sensing infrastructure presented in this thesis should be
trivial, although characterization, precision, accuracy etc. of these new sensors would
need to be revisited.

Conclusion
In summary of this thesis, a device has been envisioned, developed, and evaluated to
support physicians in the ongoing initiative to improve two stage revision outcomes.
Reflecting on the previously proposed problem definition, to “Develop a diagnostic
solution specifically suitable for use during treatment for total knee arthroplasty
infection” it is clear that a purpose built device was engineered to serve exactly such a
purpose.
Reconsidering the initial study objectives proposed in Section 1.4, an objective look at
the research contributions of this thesis may be conducted. First, there was an objective to
characterize the proposed sensing device and determine suitability of the sensing,
logging, and transmission performance in an infection telemetry application. Based on
inferences of the stimuli/environment according to existing literature, and the
observations made, the device performance is certainly adequate for the intended usage
case. Second, an evaluation of the mechanical performance of the device showed promise
for the current embodiment’s compatibility with bone cement spacer applications,
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although this will require further study to claim with statistical confidence. Finally, while
this study does have some limitations and some iteration is required, the observed results
certainly indicate the feasibility of instrumenting the knee spacer to improve the revision
process going forward.
More critically, a thorough engineering design process has laid the groundwork for
intelligent, efficient iteration of the proposed platform technology to address logistical
challenges and streamline future success of this project. The outcome of this research
offers unique opportunity to the field of sensing in orthopaedics and infection
management. It has displayed with great clarity that technology in computing, batteries,
sensing, and wireless communications is approaching, or perhaps has already reached, the
point of widespread feasibility for a plurality of biotelemetric solutions to medical
problems. Other groups developing solutions to sensing various biometrics should view
this contribution as a platform technology. With minor iteration the proposed device
could provide feasible path to implantation of novel sensing technology. Ideally this
technology will inspire collaboration and ultimately expedite the application of several
other developing projects within the space of infection monitoring.
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